Atopic dermatitis, strict definition

ATOPIC_STRICT

atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L20.0 Hospital discharge: ICD-9 — 6918B Hospital discharge: ICD-8 — 69100 Cause of death: ICD-10 — L20.0 Cause of death: ICD-9 — 6918B Cause of death: ICD-8 — 69100 2 out of 7 registries used, show all original rules.	15422
4. Check minimum number of events None	15422
5. Include endpoints None	15422
6. Filter based on genotype QC (FinnGen only)	15422

Control definitions (FinnGen only)

Control exclude: ATOPIC_STRICT_REIMB

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: L20
Name in latin: Eczema atopicum

NAME	ATOPIC_STRICT
CONTROL_EXCLUDE	ATOPIC_STRICT_REIMB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L200
HD_ICD_9	6918B
HD_ICD_8	69100
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L200
COD_ICD_9	6918B
COD_ICD_8	69100
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atopic dermatitis, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	15422	10892	4530
Unadjusted period prevalence (%)	3.21	3.71	2.00
Median age at first event (years)	23.36	24.50	20.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13321: Matched controls
131761

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D02AE01

ATC

carbamide; topical

6.2

323.0

1909

3442

D07AC13

ATC

mometasone; topical

5.9

323.0

6909

20455

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

5.7

323.0

3658

8216

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

323.0

3348

12922

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

7892

52292

S87

ICPC

Dermatitis/atopic eczema

7.8

323.0

950

1277

S01GX01

ATC

cromoglicic acid; ophthalmic

3.2

323.0

4531

18176

D07AB02

ATC

hydrocortisone butyrate; topical

5.3

323.0

6702

21053

R06AE07

ATC

cetirizine; oral

3.7

323.0

8634

44061

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.2

323.0

3347

12358

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

10.3

323.0

1806

1971

L20

ICD-10 Finland

Atopic dermatitis

10.7

323.0

1539

1595

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.9

323.0

1801

5105

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.4

323.0

2429

6368

E000003

ATC

9.0

323.0

1739

2157

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

323.0

2094

E000007

ATC

7.0

323.0

2108

3466

N05BB01

ATC

hydroxyzine; systemic

6.7

323.0

2091

3575

D07AD01

ATC

clobetasol; topical

3.3

323.0

2579

8919

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

6.9

323.0

3457

6340

E000006

ATC

6.3

323.0

2025

3642

H02AB06

ATC

prednisolone; systemic

2.6

323.0

6638

36615

L27.2

ICD-10 Finland

Dermatitis due to ingested food

16.4

323.0

685

433

D07CC01

ATC

betamethasone and antibiotics; topical

4.1

323.0

2798

8018

R06AX27

ATC

desloratadine; oral

2.7

323.0

5597

27797

XQ802

NOMESCO Finland

Epicutan test

13.0

323.0

2142

1915

L20.0

ICD-10 Finland

Besnier prurigo

289.8

323.0

11120

2238

D11AH01

ATC

tacrolimus; topical

1122.2

323.0

1237

D07AB08

ATC

desonide; topical

9.5

323.0

4225

6127

C01CA24

ATC

epinephrine; parenteral

3.9

323.0

1649

4610

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

323.0

1366

D07AA02

ATC

hydrocortisone; topical

8.2

323.0

5574

10630

D07AC14

ATC

methylprednisolone aceponate; topical

5.7

323.0

1182

2228

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

323.0

2227

E000002

ATC

8.2

323.0

4754

8367

D11AH02

ATC

pimecrolimus; topical

+∞

323.0

489

E0000UV

ATC

9.2

323.0

10267

35204

D07AC01

ATC

betamethasone; topical

4.9

323.0

6987

24113

D02AX

ATC

Other emollients and protectives

8.8

323.0

1324

1625

XQ800

NOMESCO Finland

Prick test

6.8

323.0

3041

5488

D07BC01

ATC

betamethasone and antiseptics; topical

4.8

323.0

2573

6295

R06AX22

ATC

ebastine; oral

2.9

323.0

3277

13449

R06AE09

ATC

levocetirizine; oral

3.5

323.0

3499

12314

E000001

ATC

7.2

323.0

6749

16409

R06AX13

ATC

loratadine; oral

3.1

323.0

3398

13292

D07BA04

ATC

hydrocortisone and antiseptics; topical

7.4

323.0

4036

7319

D11AX14

ATC

[U] tacrolimus; topical

+∞

323.0

668

D11AX15

ATC

[U] pimecrolimus; topical

+∞

319.8

307

E000004

ATC

7.9

290.4

700

920

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

14.2

282.3

497

359

R03DC03

ATC

montelukast; oral

2.5

280.5

2721

12468

R03BA02

ATC

budesonide; inhalant

2.4

279.4

2824

13214

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

279.1

2619

11788

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.7

278.7

2285

9534

J01DA01

ATC

[U] cefalexin; systemic

1.9

274.3

8350

61438

D09AB01

ATC

zinc bandage without supplements; topical

10.7

262.5

528

506

L30.3

ICD-10 Finland

Infective dermatitis

6.0

257.6

761

1326

D07AB01

ATC

clobetasone; topical

5.8

256.5

777

1397

R03BA05

ATC

fluticasone; inhalant

2.3

254.4

2927

14514

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

8.2

242.7

568

710

J01DB01

ATC

cefalexin; oral

2.1

231.1

11003

91911

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.2

230.4

2906

14937

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.6

227.7

850

1925

H02AB04

ATC

methylprednisolone; systemic

2.6

225.4

1950

8294

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

12.4

224.2

419

345

D07XB05

ATC

dexamethasone, combinations; topical

6.0

216.8

635

1091

H02AB07

ATC

prednisone; oral

2.6

215.1

1846

7800

TQW80

NOMESCO Finland

Local dermatologic skincare

6.8

212.9

568

862

R03AC03

ATC

terbutaline; inhalant

2.3

207.3

2156

10061

S01GX02

ATC

levocabastine; ophthalmic

3.1

205.4

1265

4346

D07XC01

ATC

betamethasone, combinations; topical

2.7

204.4

1574

6238

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

203.8

1207

4032

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

10.8

201.5

402

378

49300

ICD-8 Finland

Asthma, bronchiale

7.5

194.1

482

659

J45

ICD-10 Finland

Asthma

2.6

185.3

1521

6232

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

4.4

157.0

613

1442

L20.8

ICD-10 Finland

Other atopic dermatitis

8.6

154.3

350

414

J30.3

ICD-10 Finland

Other allergic rhinitis

3.5

149.8

762

2258

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

148.6

3601

22982

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.3

148.3

1541

7092

R01AD08

ATC

fluticasone; nasal

1.7

147.5

3872

25308

R03BA01

ATC

beclometasone; inhalant

2.2

146.6

1772

8743

R01AD09

ATC

mometasone; nasal

1.6

145.9

6129

45584

R06AX26

ATC

fexofenadine; oral

2.6

144.9

1167

4696

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

143.4

1658

8014

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

138.4

930

3352

R06AX18

ATC

acrivastine; oral

4.5

136.5

508

1138

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

10.1

136.1

280

279

R96

ICPC

Asthma

2.5

132.4

1140

4751

134

Kela drug reimbursment

General erythroderma

+∞

131.9

127

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

125.1

2462

14565

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.7

116.9

2994

19177

Z3231

NOMESCO Finland

Registered nurse

1.7

114.7

3189

20890

S01AD03

ATC

aciclovir; ophthalmic

3.6

112.1

545

1552

S01GX08

ATC

ketotifen; ophthalmic

3.0

109.9

690

2371

D07CB01

ATC

triamcinolone and antibiotics; topical

5.1

109.7

366

730

Z51.6

ICD-10 Finland

Desensitization to allergens

4.6

107.8

392

857

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

6.7

107.2

285

429

J01FF01

ATC

clindamycin; systemic

1.6

102.8

3035

20109

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

9.8

102.0

212

216

R01AC01

ATC

cromoglicic acid; nasal

2.7

100.7

750

2865

L30.0

ICD-10 Finland

Nummular dermatitis

3.7

98.0

459

1267

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.5

97.6

495

1457

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

94.4

3746

26622

J05AB01

ATC

aciclovir; systemic

1.7

94.3

2465

15737

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

6.6

92.8

249

380

R01AD01

ATC

beclometasone; nasal

1.8

91.3

1848

10911

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

6.9

90.4

234

340

R03AC12

ATC

salmeterol; inhalant

3.2

89.5

503

1598

R06AX12

ATC

terfenadine; oral

2.6

88.6

679

2635

R01AD05

ATC

budesonide; nasal

2.2

88.0

1008

4794

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

86.2

3012

20680

L26

ICD-10 Finland

Exfoliative dermatitis

54.0

85.8

103

395

Kela drug reimbursment

Dupilumab

+∞

85.1

S01GX09

ATC

olopatadine; ophthalmic

3.2

82.1

454

1426

D07AC03

ATC

desoximetasone; topical

5.1

80.1

265

524

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

11.0

79.7

156

142

A46

ICD-10 Finland

Erysipelas

2.0

78.5

1093

5630

J45.8

ICD-10 Finland

Mixed asthma

3.1

76.3

438

1412

R01AD12

ATC

fluticasone furoate; nasal

1.5

76.2

4120

30979

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

72.9

574

2257

XQ848

NOMESCO Finland

Dermatological photography

3.8

72.2

327

878

S29

ICPC

Skin symptom/complaint other

1.7

70.7

1793

11251

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

69.8

3142

22661

S01GX04

ATC

nedocromil; ophthalmic

3.9

69.5

302

782

B00.10

ICD-10 Finland

Herpes simplex facialis

6.1

69.2

197

326

A92

ICPC

Allergy/allergic reaction NOS

2.6

69.1

548

2165

D11AH05

ATC

dupilumab; topical

+∞

68.5

R03DA04

ATC

theophylline; systemic, rectal

2.9

68.1

442

1546

R03AC13

ATC

formoterol; inhalant

2.6

68.1

527

2052

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.9

67.4

295

769

J46

ICD-10 Finland

Status asthmaticus

3.3

66.4

360

1114

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

8.1

65.7

152

187

J05AB11

ATC

valaciclovir; oral

1.7

64.5

1428

8599

R03BC01

ATC

cromoglicic acid; inhalant

3.6

64.5

310

875

S21

ICPC

Skin texture symptom/complaint

1.8

64.2

1298

7601

L04AA01

ATC

[U] ciclosporin; systemic

4.5

64.2

238

532

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.5

64.0

549

2263

J01FA06

ATC

roxithromycin; oral

1.4

62.4

4220

32786

WQ007

NOMESCO Finland

27.3

61.4

J01FA10

ATC

azithromycin; systemic

1.4

60.2

7978

69090

H01.0

ICD-10 Finland

Blepharitis

2.1

60.0

732

3564

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

7.1

58.6

148

209

S01GX05

ATC

lodoxamide; ophthalmic

4.2

58.1

230

548

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

9.8

58.1

120

122

R06.0

ICD-10 Finland

Dyspnoea

1.5

57.7

2166

14925

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

56.6

6560

55374

L50.3

ICD-10 Finland

Dermatographic urticaria

3.4

56.5

292

873

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

56.3

794

4097

L30.8

ICD-10 Finland

Other specified dermatitis

3.2

56.2

314

994

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

7.0

55.3

141

202

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.7

54.1

398

1506

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.6

54.0

253

700

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

53.3

1795

12041

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

53.1

443

1797

R03BA08

ATC

ciclesonide; inhalant

1.8

53.0

917

5091

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

8.2

52.9

121

147

R06AX11

ATC

astemizole; oral

2.4

52.5

479

2036

J02AC02

ATC

itraconazole; systemic

1.5

51.0

1788

12092

J01FA01

ATC

erythromycin; systemic

1.5

50.8

1982

13732

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

50.5

974

5599

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

3.1

50.2

287

923

R02

ICPC

Shortness of breath/dyspnoea

1.7

49.8

1155

7023

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

49.8

530

2427

L28.1

ICD-10 Finland

Prurigo nodularis

7.5

49.5

120

160

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.3

48.3

455

1968

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

48.2

590

2872

L04AD01

ATC

ciclosporin; systemic

3.2

48.1

265

832

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.9

47.8

202

513

WQ000

NOMESCO Finland

Hyposensibilisation

4.6

47.5

172

377

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

47.3

2396

17484

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

47.2

3543

27706

E0001A1

ATC

2.5

47.2

403

1656

L50.0

ICD-10 Finland

Allergic urticaria

2.5

46.9

378

1504

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.6

45.5

137

245

R03BB04

ATC

tiotropium bromide; inhalant

2.0

45.4

613

3107

50708

ICD-8 Finland

Hay fever, Alia definita

7.9

45.1

105

132

J01AA02

ATC

doxycycline; systemic

1.3

44.8

8247

73182

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.4

44.8

226

665

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

9.4

44.4

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.7

44.1

944

5597

R01AD11

ATC

triamcinolone; nasal

1.7

44.1

968

5786

68408

ICD-8 Finland

Impetigo, Alia definita

21.9

43.6

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

14.8

43.2

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.9

43.0

144

291

J02AB02

ATC

ketoconazole; oral

2.5

42.8

349

1400

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

42.1

402

1750

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

6.0

41.9

118

195

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

41.1

2810

21551

R01AC02

ATC

levocabastine; nasal

2.3

40.8

399

1759

L08.0

ICD-10 Finland

Pyoderma

4.3

40.3

156

366

R06AE08

ATC

4.2

40.3

159

380

R03CC02

ATC

salbutamol; systemic

1.5

40.3

1345

8962

N02BE01

ATC

paracetamol; systemic, rectal

1.3

40.2

9803

89596

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.6

39.4

142

311

M79.6

ICD-10 Finland

Pain in limb

1.3

39.3

3589

28753

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

38.8

4213

34573

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

38.7

1720

12181

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

38.4

971

6028

D06BB03

ATC

aciclovir; topical

2.0

38.4

521

2644

WZC30

NOMESCO Finland

Teaching

1.6

37.7

1097

7067

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

37.6

3585

28861

J02AC01

ATC

fluconazole; systemic

1.3

37.5

4747

39715

M25.5

ICD-10 Finland

Pain in joint

1.3

37.1

3050

24016

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

36.8

2270

17066

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

36.5

417

1972

N02AX02

ATC

tramadol; systemic, rectal

1.3

36.1

3614

29261

S01GX06

ATC

emedastine; ophthalmic

3.3

36.0

191

586

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

35.7

727

4238

A02BC02

ATC

pantoprazole; systemic

1.3

35.7

6244

54268

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

43.6

35.7

68600

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

32.6

35.1

D07AB09

ATC

triamcinolone; topical

6.1

34.9

158

SPAT1058

SPAT

PEF monitoring instruction

1.7

34.5

765

4577

XQ817

NOMESCO Finland

15.9

34.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

34.2

1273

8675

S76

ICPC

Skin infection other

2.0

33.9

457

2312

WQ021

NOMESCO Finland

19.5

33.6

UJF32

NOMESCO Finland

Coloscopy

1.4

33.3

1901

14079

Z3226

NOMESCO Finland

Physiotherapist

1.4

33.3

1751

12779

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

6.4

33.1

139

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

33.0

1319

9122

R03BC03

ATC

nedocromil; inhalant

1.8

32.9

638

3663

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

4.4

32.9

123

281

L01

ICD-10 Finland

Impetigo

2.7

32.8

230

848

XQ830

NOMESCO Finland

Exposure to foodstuff

20.3

32.8

WIX00

NOMESCO Finland

Allergy cleanup guidance

12.5

32.7

J01FA09

ATC

clarithromycin; systemic

1.3

32.6

3573

29197

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

32.5

2020

15176

E000005

ATC

14.4

32.4

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

31.9

648

3775

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

31.9

1746

12828

WQ066

NOMESCO Finland

29.8

31.4

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

4.7

31.3

109

232

D05BB02

ATC

acitretin; oral

2.9

31.0

193

662

J01DA06

ATC

[U] cefuroxime; systemic

1.4

31.0

1441

10265

J01XC01

ATC

fusidic acid; systemic

3.3

30.9

159

478

Z2221

NOMESCO Finland

Medical doctor

1.3

30.6

2995

24068

F29

ICPC

Eye symptom/complaint other

1.6

30.4

848

5397

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

6.5

30.4

122

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

30.2

459

2433

R06.2

ICD-10 Finland

Wheezing

1.9

30.1

468

2500

WXQ24

NOMESCO Finland

UVB/UVA light therapy

37.7

30.0

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

5.0

29.9

196

D07XB02

ATC

triamcinolone, combinations; topical

3.3

29.7

152

456

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

29.4

1884

14202

H10

ICD-10 Finland

Conjunctivitis

1.6

29.0

749

4675

F03

ICPC

Eye discharge

1.6

28.9

714

4399

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

28.9

3649

30263

D06BX01

ATC

metronidazole; topical

1.5

28.9

990

6618

D07XA01

ATC

hydrocortisone, combinations; topical

6.8

28.8

106

L04AX01

ATC

azathioprine; systemic

1.8

28.5

480

2637

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

11.2

28.5

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

28.2

431

2289

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

28.1

2430

19160

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

7.6

28.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

28.0

1106

7617

L17

ICPC

Foot/toe symptom/complaint

1.3

28.0

2425

19124

J01AA07

ATC

tetracycline; systemic

1.4

27.6

1853

14054

WQ020

NOMESCO Finland

22.0

27.6

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.7

27.6

196

732

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

27.5

4845

41693

ZXE00

NOMESCO Finland

One hour or less

1.2

27.4

4207

35648

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

27.1

6262

55430

J01AA04

ATC

lymecycline; systemic

1.4

27.0

1674

12535

L28.0

ICD-10 Finland

Lichen simplex chronicus

3.7

26.9

120

323

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

19.8

26.7

ZY010

NOMESCO Finland

Hospital outpatient

1.6

26.5

712

4486

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

26.4

1391

10129

R05

ICD-10 Finland

Cough

1.3

26.3

1777

13493

L50.8

ICD-10 Finland

Other urticaria

2.4

26.2

230

962

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

26.2

245

1060

S88

ICPC

Dermatitis contact/allergic

2.3

26.1

246

1066

M54.5

ICD-10 Finland

Low back pain

1.3

26.0

3469

28874

68409

ICD-8 Finland

Impetigo, Unspecified

11.6

25.9

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

25.8

264

1192

R05

ICPC

Cough

1.3

25.8

2383

18935

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

5.2

25.6

152

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

25.3

537

3173

J20

ICD-10 Finland

Acute bronchitis

1.5

24.9

878

5899

R03DC01

ATC

zafirlukast; oral

3.1

24.8

138

442

R51.80

ICD-10 Finland

Headache

1.3

24.8

1800

13806

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.2

24.7

131

405

R50.9

ICD-10 Finland

Fever, unspecified

1.4

24.5

1386

10209

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

24.5

693

4423

Z71.8

ICD-10 Finland

Other specified counselling

1.3

24.4

2796

22819

H01

ICPC

Ear pain/earache

1.4

24.2

1370

10091

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

24.2

124

374

69200

ICD-8 Finland

Other eczema and dermatitis, Due to detergents

19.8

24.1

R74

ICPC

Upper respiratory infection acute

1.2

24.0

4153

35516

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

23.7

742

4853

J01CF05

ATC

flucloxacillin; systemic

1.9

23.6

352

1853

J01DB05

ATC

cefadroxil; oral

1.7

23.6

460

2652

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.3

23.5

227

999

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

8.6

23.5

N03AX16

ATC

pregabalin; oral

1.3

23.2

1895

14776

L13.0

ICD-10 Finland

Dermatitis herpetiformis

5.8

23.2

113

WX002

NOMESCO Finland

Sedation and analgesia

1.4

23.1

1507

11358

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.7

23.1

522

3140

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

53.5

22.9

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

22.8

2386

19235

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

22.5

3240

27120

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

22.5

528

3210

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

22.4

1903

14912

V01AA05

ATC

tree pollen; parenteral

2.9

22.2

134

453

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

22.1

645

4150

Z2446

NOMESCO Finland

Social worker

1.5

22.1

725

4795

R4110

NOMESCO Finland

Physiotherapy

1.3

22.0

2277

18315

D07AB10

ATC

alclometasone; topical

5.2

22.0

129

R53

ICD-10 Finland

Malaise and fatigue

1.3

21.9

1957

15445

L30

ICD-10 Finland

Other dermatitis

2.2

21.8

220

988

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

21.7

3411

28807

S18

ICPC

Laceration/cut

1.2

21.7

3616

30731

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.9

21.5

132

452

R97

ICPC

Allergic rhinitis

2.0

21.5

292

1485

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

21.4

9064

84125

A07AA02

ATC

nystatin; oral

1.7

21.2

418

2419

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

21.1

854

5904

50709

ICD-8 Finland

Hay fever, Unspecified

4.3

21.1

179

J01DA08

ATC

[U] cefaclor; oral

1.3

21.0

1789

14014

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

20.9

2499

20445

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

7.8

20.9

B00.5

ICD-10 Finland

Herpesviral ocular disease

6.2

20.9

XQ899

NOMESCO Finland

Other assessment of skin

4.7

20.8

150

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

20.8

440

2599

A02BC01

ATC

omeprazole; systemic

1.3

20.7

2232

18036

S02

ICPC

Pruritus

1.8

20.6

386

2194

WQ064

NOMESCO Finland

36.8

20.6

D01AC02

ATC

miconazole; topical

1.6

20.6

554

3491

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

20.5

679

4498

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

20.5

2621

21605

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

20.5

2742

22722

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

109.0

20.5

N06AB04

ATC

citalopram; systemic

1.3

20.5

1936

15380

L23

ICD-10 Finland

Allergic contact dermatitis

3.9

20.3

214

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

20.2

699

4673

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

20.2

1677

13084

D05AX52

ATC

calcipotriol, combinations; topical

1.7

20.2

437

2597

S01AA13

ATC

fusidic acid; ophthalmic

1.7

20.1

385

2204

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

9.1

20.1

S06

ICPC

Rash localized

1.6

20.0

499

3085

69109

ICD-8 Finland

Infantile eczema and related conditions, Unspecified

12.9

20.0

J01MA02

ATC

ciprofloxacin; systemic

1.2

19.9

3140

26479

K90.0

ICD-10 Finland

Coeliac disease

1.9

19.9

292

1530

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.6

19.9

149

50702

ICD-8 Finland

Hay fever, Aestivalis

18.6

19.8

A02BC05

ATC

esomeprazole; systemic

1.2

19.7

3521

30082

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

19.6

596

3868

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

9.7

19.4

L71.8

ICD-10 Finland

Other rosacea

2.7

19.4

136

507

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

19.3

691

4654

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

19.3

998

7227

B07.9

ICD-10 Finland

Verruca simplex

1.7

19.1

385

2242

6840A

ICD-9 Finland

Impetigo[IMPETIGO CONTAGIOSA]

11.6

19.0

S01

ICPC

Pain/tenderness of skin

1.7

18.9

376

2182

ZXA05

NOMESCO Finland

Left side

1.3

18.9

1789

14199

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

18.9

228

1108

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

18.8

751

5175

L71.9

ICD-10 Finland

Rosacea, unspecified

2.2

18.8

201

929

J01CA04

ATC

amoxicillin; systemic

1.2

18.8

10552

99796

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

18.7

1497

11614

L16

ICPC

Ankle symptom/complaint

1.4

18.6

1088

8049

H18.6

ICD-10 Finland

Keratoconus

3.6

18.6

232

XQ801

NOMESCO Finland

Intracutantest

4.5

18.4

143

N05BA04

ATC

oxazepam; oral

1.2

18.3

2311

18995

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

18.3

125

458

M03BX02

ATC

tizanidine; oral

1.2

18.2

6669

60638

D11AH04

ATC

alitretinoin; oral

13.4

18.1

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.0

18.0

106

355

N06AX11

ATC

mirtazapine; oral

1.2

18.0

3015

25538

ZXA10

NOMESCO Finland

Bilateral

1.3

17.8

1444

11217

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

17.8

806

5697

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

17.8

1174

8852

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

17.7

5710

51326

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

17.5

983

7223

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

17.4

1560

12282

R42

ICD-10 Finland

Dizziness and giddiness

1.3

17.4

1566

12334

F73

ICPC

Eye infection/inflammation other

2.0

17.4

210

1025

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

17.3

1779

14258

ZXD05

NOMESCO Finland

Urgent procedure

1.2

17.3

3190

27261

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

17.2

215

1061

L71.0

ICD-10 Finland

Perioral dermatitis

2.1

17.1

197

942

SPAT1267

SPAT

Desensitisation

4.6

17.0

128

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

9.1

16.9

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

16.9

388

2348

M79.1

ICD-10 Finland

Myalgia

1.3

16.8

1287

9914

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

16.8

642

4386

J01MA12

ATC

levofloxacin; systemic

1.3

16.7

1257

9658

H60.8

ICD-10 Finland

Other otitis externa

1.9

16.7

261

1402

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

16.7

310

1764

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.4

16.7

138

567

J04BA02

ATC

dapsone; oral

4.1

16.6

159

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.6

16.6

123

G44.2

ICD-10 Finland

Tension-type headache

1.3

16.5

1401

10948

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

5.2

16.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

16.5

1389

10844

SPAT1057

SPAT

Peak expiratory flow measurement

2.0

16.4

200

979

X58

ICD-10 Finland

Exposure to other specified factors

1.3

16.4

1406

11006

A04

ICPC

Weakness/tiredness general

1.3

16.3

1344

10462

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

16.2

334

1962

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.0

16.1

213

1077

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

16.0

6526

59566

N06AA12

ATC

doxepin; systemic

1.7

16.0

334

1966

L03

ICPC

Low back symptom/complaint

1.2

16.0

2426

20304

505

Kela drug reimbursment

Allergy to cow's milk in infants

8.3

16.0

T78.3

ICD-10 Finland

Angioneurotic oedema

2.4

16.0

133

547

M01AC05

ATC

lornoxicam; systemic, rectal

18.3

15.9

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.5

15.8

211

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.2

15.8

155

692

L01

ICPC

Neck symptom/complaint

1.3

15.7

1368

10725

N03AX12

ATC

gabapentin; oral

1.3

15.7

1181

9075

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

15.6

683

4793

49308

ICD-8 Finland

Asthma, Alia definita

6.7

15.5

N06AB06

ATC

sertraline; oral

1.3

15.5

1213

9375

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

15.4

307

1787

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

15.3

3034

26053

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

15.3

4377

38802

S01XA02

ATC

retinol; ophthalmic

5.4

15.3

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

7.5

15.2

H16.0

ICD-10 Finland

Corneal ulcer

1.6

15.1

428

2737

F02

ICPC

Red eye

1.6

15.1

401

2522

WX110

NOMESCO Finland

Local anesthesy

1.2

15.1

8501

79368

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

15.0

1433

11364

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.8

15.0

245

1337

A07EB01

ATC

cromoglicic acid; oral

12.9

15.0

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

15.0

1319

10354

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.4

14.9

211

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

14.9

267

1505

A02BC03

ATC

lansoprazole; oral

1.2

14.9

2152

17909

Z01.2

ICD-10 Finland

Dental examination

1.2

14.8

5042

45283

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

14.8

569

3897

B00.11

ICD-10 Finland

Herpes simplex labialis

2.1

14.7

158

736

WZA90

NOMESCO Finland

Other doctors statement

1.2

14.7

2592

22007

D07XB01

ATC

flumetasone, combinations; topical

3.9

14.7

149

A02BA02

ATC

ranitidine; systemic

1.3

14.6

1259

9849

R60.0

ICD-10 Finland

Localized oedema

1.4

14.6

662

4679

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

14.6

751

5434

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

5.4

14.6

A03

ICPC

Fever

1.2

14.4

2147

17917

XQ820

NOMESCO Finland

Exposure to medicinal substance

3.8

14.4

161

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.9

14.4

202

1046

D01AE15

ATC

terbinafine; topical

1.5

14.4

449

2940

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

14.3

6232

56964

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

7.2

14.3

P01AB01

ATC

metronidazole; oral, rectal

1.2

14.3

3922

34611

C03CA01

ATC

furosemide; systemic

1.3

14.2

1170

9099

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

14.2

4226

37523

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

14.1

569

3935

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

14.1

543

3718

B00.0

ICD-10 Finland

Eczema herpeticum

3.2

14.1

221

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

14.1

1078

8304

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

14.0

8612

80670

K02.1

ICD-10 Finland

Caries of dentine

1.2

13.9

7238

66965

C09CA06

ATC

candesartan; oral

1.3

13.9

1569

12702

Y1202

ICD-8 Finland

Skin tests, Allergy tests

5.7

13.8

X57

ICD-10 Finland

Unspecified privation

1.9

13.8

189

971

H29

ICPC

Ear symptom/complaint other

1.4

13.8

758

5547

N05CF01

ATC

zopiclone; oral

1.2

13.8

2358

19950

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

13.7

2391

20258

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

13.7

3419

29908

SPAT1283

SPAT

Restricted health certificate

1.2

13.6

2917

25185

R03AC04

ATC

fenoterol; inhalant

6.2

13.6

L12

ICPC

Hand/finger symptom/complaint

1.3

13.6

1455

11702

SPAT1260

SPAT

Consultation of another employee

1.2

13.6

1606

13065

R21

ICPC

Throat symptom/complaint

1.2

13.6

2992

25895

SPAT1301

SPAT

No procedures

1.2

13.6

3039

26339

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.5

13.5

181

M01AE02

ATC

naproxen; oral, rectal

1.1

13.5

6674

61458

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

13.4

430

2832

B02.9

ICD-10 Finland

Zoster without complication

1.6

13.4

325

2002

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

13.4

293

1757

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

5.9

13.3

L70.0

ICD-10 Finland

Acne vulgaris

1.5

13.2

497

3390

V01AA02

ATC

grass pollen; systemic

3.3

13.1

201

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

13.1

714

5219

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

1.8

13.1

217

1194

H02AB09

ATC

hydrocortisone; systemic

1.8

13.1

228

1274

D11

ICPC

Diarrhoea

1.3

13.1

1319

10533

S01AA02

ATC

chlortetracycline; ophthalmic

3.4

13.0

181

J01MA14

ATC

moxifloxacin; systemic

1.4

13.0

611

4352

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

13.0

700

5108

13300

ICD-8 Finland

5.1

13.0

G47.3

ICD-10 Finland

Sleep apnoea

1.2

13.0

1520

12350

N05AH04

ATC

quetiapine; oral

1.2

12.9

1811

15007

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

12.9

230

1296

49099

ICD-8 Finland

Bronchitis, unspecified

2.6

12.9

346

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

12.9

862

6510

N06AX16

ATC

venlafaxine; oral

1.2

12.8

1462

11841

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

2.6

12.8

365

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

12.8

755

5593

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

1.9

12.7

180

936

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.3

12.7

1253

9974

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

12.5

2659

22919

R06AD02

ATC

promethazine; systemic, rectal

15.2

12.5

D01AC03

ATC

econazole; topical

1.5

12.5

375

2436

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

12.4

1078

8442

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

12.4

444

2997

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

12.4

683

5003

R49.08

ICD-10 Finland

Other specified dysphonia

1.9

12.3

167

859

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

12.3

1468

11948

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

12.3

460

3138

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

12.2

840

6367

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

12.2

990

7680

R06AX25

ATC

mizolastine; oral

4.0

12.2

120

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

12.2

178

940

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

12.2

489

3381

Z00.0

ICD-10 Finland

General medical examination

1.2

12.2

1762

14644

J01CF02

ATC

cloxacillin; systemic

2.0

12.1

154

771

SPAT1059

SPAT

Spirometry at the office

1.6

12.1

343

2198

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

12.1

1906

15974

R03CC03

ATC

terbutaline; systemic

1.5

12.1

357

2312

A07EC02

ATC

mesalazine; oral, rectal

1.4

12.1

496

3445

D05AX02

ATC

calcipotriol; topical

1.7

12.0

242

1416

ZXA00

NOMESCO Finland

Right side

1.2

12.0

1842

15391

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

12.0

1755

14599

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

12.0

765

5733

K50.8

ICD-10 Finland

Other Crohn disease

1.9

12.0

168

875

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

17.8

11.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

11.9

680

5005

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.3

11.9

766

5749

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.3

11.9

798

6030

L56.4

ICD-10 Finland

Polymorphous light eruption

3.7

11.9

133

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

11.9

3670

32580

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.2

11.9

1645

13609

R03BB01

ATC

ipratropium bromide; inhalant

1.9

11.8

165

857

R29

ICPC

Respiratory symptom/complaint other

1.4

11.8

564

4026

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

11.8

458

3145

N06AB03

ATC

fluoxetine; oral

1.3

11.8

1165

9277

Z2445

NOMESCO Finland

Psychologist

1.4

11.8

513

3603

R07.0

ICD-10 Finland

Pain in throat

1.4

11.7

692

5129

D07BA01

ATC

prednisolone and antiseptics; topical

14.5

11.7

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

3.7

11.7

135

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

11.7

3473

30732

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

11.7

1811

15151

N01

ICPC

Headache

1.2

11.6

1599

13212

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

11.6

399

2677

69283

ICD-8 Finland

Other eczema and dermatitis, Dysidroticum (pompholyx)

64.3

11.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.1

11.5

4875

44231

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.7

11.5

284

L85.3

ICD-10 Finland

Xerosis cutis

2.7

11.5

276

RS340

NOMESCO Finland

4.3

11.5

R52.9

ICD-10 Finland

Pain, unspecified

1.4

11.5

679

5030

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

11.4

168

891

48609

ICD-8 Finland

Pneumonia, unspecified

2.0

11.4

149

757

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

11.3

746

5623

WX290

NOMESCO Finland

Other blockade of nerve

1.1

11.3

5869

53953

C07AB07

ATC

bisoprolol; oral

1.2

11.3

2816

24570

UKC02

NOMESCO Finland

Cystoscopy

1.3

11.3

784

5952

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.2

11.3

111

502

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

11.3

293

1842

M79.7

ICD-10 Finland

Fibromyalgia

1.6

11.3

312

1992

EMB30

NOMESCO Finland

Adenotomy

1.4

11.3

560

4030

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

11.2

3201

28224

N06AX21

ATC

duloxetine; oral

1.3

11.2

956

7471

L21.0

ICD-10 Finland

Seborrhoea capitis

2.3

11.2

418

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

11.2

902

6999

SPAT1240

SPAT

Therapeutic discussion

1.2

11.1

1452

11932

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

11.1

438

3021

-1

NOMESCO Finland

1.1

11.1

4359

39326

L29.8

ICD-10 Finland

Other pruritus

2.3

11.0

413

L50.2

ICD-10 Finland

Urticaria due to cold and heat

3.5

11.0

142

RJ411

NOMESCO Finland

3.3

11.0

163

AA1AD

NOMESCO Finland

CT of head and brain

1.2

10.9

1438

11822

C84.0

ICD-10 Finland

Mycosis fungoides

11.0

10.9

QXA70

NOMESCO Finland

Guidance related to rash and skin care

11.0

10.9

D07BB01

ATC

flumetasone and antiseptics; topical

3.0

10.9

192

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

10.8

721

5443

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.1

10.8

115

539

R4190

NOMESCO Finland

Nutritional therapy

1.5

10.8

328

2140

L50.1

ICD-10 Finland

Idiopathic urticaria

2.5

10.8

314

S99

ICPC

Skin disease other

2.0

10.7

137

690

D07AC09

ATC

budesonide; topical

5.9

10.7

M10.9

ICD-10 Finland

Gout, unspecified

1.6

10.7

246

1499

N05CD07

ATC

temazepam; oral

1.4

10.7

586

4290

L13

ICPC

Hip symptom/complaint

1.3

10.7

946

7431

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

10.7

595

4367

S84

ICPC

Impetigo

2.4

10.6

346

H60.1

ICD-10 Finland

Cellulitis of external ear

2.1

10.6

120

576

A12

ICPC

ALLERGY/ALLERGIC REACTION

3.0

10.6

190

SPAT1254

SPAT

Administration of medicine

1.2

10.6

1378

11318

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

10.6

327

2144

EMB10

NOMESCO Finland

Tonsillectomy

1.3

10.6

841

6509

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

10.6

555

4035

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.4

10.5

508

3641

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

10.5

213

1252

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

10.5

379

2570

E000008

ATC

3.3

10.4

154

49309

ICD-8 Finland

Asthma, Unspecified

5.4

10.4

50704

ICD-8 Finland

Hay fever, Conjunctivitis allergica

9.9

10.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

10.4

587

4320

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

10.4

469

3321

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

10.4

249

1533

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

10.4

428

2981

M04AA01

ATC

allopurinol; systemic

1.4

10.3

474

3365

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

2.2

10.3

424

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

10.3

366

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.4

10.3

404

2785

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

10.3

463

3278

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.0

10.3

189

A01AB09

ATC

miconazole; local oral

1.3

10.2

620

4613

L02

ICPC

Back symptom/complaint

1.3

10.2

924

7272

6925B

ICD-9 Finland

Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFACTA EX ALIMENTIS ALLERGICA,VÄLITÖN]

23.1

10.2

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

9.4

10.1

50701

ICD-8 Finland

Hay fever, Vernalis

9.4

10.1

R13

ICD-10 Finland

Dysphagia

1.5

10.1

375

2554

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.0

10.1

128

645

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.3

10.0

397

J32.4

ICD-10 Finland

Chronic pansinusitis

2.0

10.0

116

563

SPAT1312

SPAT

General health counselling

1.1

10.0

3762

33778

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.0

10.0

120

592

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

8.3

9.9

D05AX03

ATC

calcitriol; topical

2.2

9.9

444

L14

ICPC

Leg/thigh symptom/complaint

1.4

9.9

544

3984

SPAT1310

SPAT

Counselling related to known health issue

1.1

9.9

3348

29838

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

1.7

9.9

199

1169

L60.0

ICD-10 Finland

Ingrowing nail

1.5

9.9

373

2552

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

9.9

661

4996

J35.0

ICD-10 Finland

Chronic tonsillitis

1.3

9.9

721

5518

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

9.9

417

2918

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

5.0

9.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

9.8

714

5459

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

9.8

443

3137

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

3.5

9.8

125

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.1

9.8

109

521

6918A

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA INFANTUM]

25.7

9.7

J04.0

ICD-10 Finland

Acute laryngitis

1.4

9.7

405

2829

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.8

9.7

155

849

A06AD11

ATC

lactulose; oral

1.3

9.7

742

5715

07900

ICD-8 Finland

Other viral diseases, Molluscum contagiosum

5.9

9.7

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

9.7

1182

9642

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.0

9.6

115

564

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

9.6

974

7776

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.7

9.6

206

1232

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

4.4

9.6

N03AX09

ATC

lamotrigine; oral

1.4

9.6

532

3904

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

9.6

375

2588

S06.0

ICD-10 Finland

Concussion

1.3

9.6

966

7708

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.1

9.5

6764

63124

D07AC04

ATC

fluocinolone acetonide; topical

6.7

9.5

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

9.5

273

1764

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.5

9.5

327

2199

E66.8

ICD-10 Finland

Other obesity

1.4

9.5

498

3626

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

9.5

993

7965

R83

ICPC

Respiratory infection other

1.1

9.4

3365

30081

P29

ICPC

Psychological sympt/compl other

1.3

9.4

739

5712

1200

NOMESCO Finland

6.3

9.4

L73.8

ICD-10 Finland

Other specified follicular disorders

2.2

9.4

404

H60

ICD-10 Finland

Otitis externa

1.4

9.4

419

2962

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

5.9

9.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

9.4

2271

19735

L50.5

ICD-10 Finland

Cholinergic urticaria

5.3

9.4

A03FA02

ATC

cisapride; oral, rectal

1.4

9.4

464

3344

SPAT1255

SPAT

Intravenous administration of medicine

1.4

9.4

413

2916

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

9.3

707

5439

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.8

9.3

148

810

5798A

ICD-9 Finland

Intestinal malabsorption, Other specified intestinal malabsorption[RUOKA-AINEALLERGIAAN LIITTYVÄ MALABSORPTIO]

7.4

9.3

L28.2

ICD-10 Finland

Other prurigo

3.3

9.3

136

Z01.7

ICD-10 Finland

Laboratory examination

1.3

9.3

930

7418

6924B

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E METALLIS ALLERGICA]

21.4

9.3

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

9.3

3729

33597

K50.9

ICD-10 Finland

Crohn disease, unspecified

1.8

9.3

153

846

J01EA01

ATC

trimethoprim; systemic

1.2

9.3

2257

19623

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

9.2

410

2896

G43.9

ICD-10 Finland

Migraine, unspecified

1.3

9.2

730

5647

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

9.2

1225

10079

L09

ICPC

Arm symptom/complaint

1.4

9.2

380

2647

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

9.2

160

900

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

9.2

8558

81043

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.3

9.2

671

5135

48509

ICD-8 Finland

Bronchopneumonia, unspecified

2.0

9.2

105

509

SPAT1263

SPAT

Sampling

1.1

9.2

4585

41877

A07EA02

ATC

hydrocortisone; rectal

1.7

9.2

183

1075

N06AB10

ATC

escitalopram; oral

1.2

9.1

2314

20180

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

9.0

189

1126

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.4

9.0

403

2852

M48.0

ICD-10 Finland

Spinal stenosis

1.4

9.0

483

3528

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.7

9.0

228

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

9.0

4324

39388

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

8.9

617

4683

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

8.9

471

3431

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

1.7

8.9

161

917

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

8.9

399

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

8.9

292

1942

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

8.9

421

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.5

8.9

283

1871

K11.2

ICD-10 Finland

Sialoadenitis

1.6

8.9

243

1553

SDA02

NOMESCO Finland

Parodonthologic therapy

1.1

8.9

3542

31878

M01AH05

ATC

etoricoxib; oral

1.1

8.9

5745

53236

Z50.5

ICD-10 Finland

Speech therapy

1.9

8.8

120

623

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.3

8.8

620

4722

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.4

8.8

422

3024

H03AA01

ATC

levothyroxine sodium; systemic

1.2

8.8

1929

16625

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

8.8

399

2833

H10.2

ICD-10 Finland

Other acute conjunctivitis

1.9

8.8

125

658

L20

ICPC

Joint symptom/complaint NOS

1.5

8.7

284

1884

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.3

8.7

345

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.1

8.7

3855

34915

KMAK

NOMESCO Finland

1.1

8.7

6069

56446

L03.2

ICD-10 Finland

Cellulitis of face

2.4

8.7

289

P76

ICPC

Depressive disorder

1.3

8.7

746

5839

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

8.7

153

865

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

1.6

8.6

232

1473

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

3.1

8.6

145

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.3

8.6

771

6070

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.1

8.5

3777

34202

L63.9

ICD-10 Finland

Alopecia areata, unspecified

2.4

8.5

275

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.5

8.5

271

1793

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

8.5

6868

64365

N06AA09

ATC

amitriptyline; systemic

1.3

8.5

598

4553

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

8.5

423

3053

P01

ICPC

Feeling anxious/nervous/tense

1.2

8.5

1641

13990

RJ420

NOMESCO Finland

3.4

8.5

114

SBB10

NOMESCO Finland

Teeth copy

1.3

8.5

884

7083

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

8.4

729

5708

L11

ICPC

Wrist symptom/complaint

1.3

8.4

826

6572

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

8.4

142

795

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

8.4

1158

9568

K50.0

ICD-10 Finland

Crohn disease of small intestine

1.7

8.4

149

849

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.3

8.4

576

4375

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.2

8.3

1130

9320

R05FB02

ATC

cough suppressants and expectorants

1.1

8.3

2880

25663

L63.8

ICD-10 Finland

Other alopecia areata

2.9

8.3

170

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.0

8.3

154

RS221

NOMESCO Finland

1.8

8.3

130

711

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.2

8.3

895

7199

N05BA01

ATC

diazepam; systemic, rectal

1.2

8.3

973

7900

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

8.3

719

5636

K30

ICD-10 Finland

Functional dyspepsia

1.3

8.3

828

6602

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

8.3

239

1547

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

1.7

8.3

164

964

R06.5

ICD-10 Finland

Mouth breathing

1.3

8.2

649

5021

H01.89

ICD-10 Finland

Other specified inflammation of eyelids

2.5

8.2

234

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

4.2

8.2

ZX112

NOMESCO Finland

Subcutaneous

1.8

8.2

138

773

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

8.1

382

2730

N06AX05

ATC

trazodone; oral

1.6

8.1

206

1292

M10.0

ICD-10 Finland

Idiopathic gout

1.9

8.1

116

613

M01AB05

ATC

diclofenac; systemic, rectal

1.1

8.1

6648

62289

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

1.7

8.1

157

915

L15

ICPC

Knee symptom/complaint

1.2

8.1

1723

14810

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.0

8.1

146

RD210

NOMESCO Finland

1.6

8.1

191

1178

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

8.1

349

2455

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

8.1

133

737

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.4

8.1

407

2946

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

8.1

258

1710

R51

ICD-10 Finland

Headache

1.3

8.1

539

4079

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

8.1

385

2760

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.6

8.0

197

1225

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

8.0

460

3397

P74

ICPC

Anxiety disorder/anxiety state

1.3

8.0

485

3611

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.3

8.0

819

6547

69830

ICD-8 Finland

Pruritus and related conditions, Lichenification and lichen simplex chronicus

17.0

8.0

WW200

NOMESCO Finland

Immunization

1.5

8.0

225

1447

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.1

8.0

3866

35165

J01

ICD-10 Finland

Acute sinusitis

1.3

8.0

483

3598

L10

ICPC

Elbow symptom/complaint

1.4

8.0

396

2856

69250

ICD-8 Finland

Other eczema and dermatitis, Due to food

21.8

8.0

N30.0

ICD-10 Finland

Acute cystitis

1.2

8.0

1205

10046

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.9

8.0

107

556

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.3

7.9

810

6476

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

7.9

368

2628

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

7.9

536

4064

H92.0

ICD-10 Finland

Otalgia

1.3

7.9

501

3763

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

7.9

607

4685

127

Kela drug reimbursment

Transplant complication

1.8

7.9

118

636

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.0

7.9

460

S70

ICPC

Herpes zoster

1.9

7.9

116

622

L13.9

ICD-10 Finland

Bullous disorder, unspecified

2.8

7.8

166

J01FA15

ATC

telithromycin; oral

1.2

7.8

815

6534

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

7.8

1914

16634

M01AC06

ATC

meloxicam; systemic, rectal

1.1

7.8

2848

25457

H60.3

ICD-10 Finland

Other infective otitis externa

1.6

7.8

173

1052

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.4

7.8

401

2913

R01AD04

ATC

flunisolide; nasal

2.6

7.7

197

B34.9

ICD-10 Finland

Viral infection, unspecified

1.4

7.7

318

2220

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.4

7.7

376

2704

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

7.7

367

2635

S71

ICPC

Herpes simplex

2.2

7.7

355

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.7

421

3093

H16.9

ICD-10 Finland

Keratitis, unspecified

1.7

7.7

139

798

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

4.8

7.6

J33.8

ICD-10 Finland

Other polyp of sinus

1.8

7.6

131

736

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.6

312

2175

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

7.6

1054

8711

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

7.6

283

1937

H70

ICPC

Otitis externa

1.6

7.6

168

1021

F01

ICPC

Eye pain

1.5

7.6

252

1687

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

7.6

791

6343

9700/3-C44.9

ICD-O-3

Mycosis fungoides of skin, NOS

18.1

7.5

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.2

7.5

857

6937

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.5

7.5

223

70404

ICD-8 Finland

Diseases of hair and hair follicles, Folliculitis NUD

24.7

7.5

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.6

7.5

175

1074

S80.0

ICD-10 Finland

Contusion of knee

1.3

7.5

608

4726

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.5

7.5

242

1608

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

7.5

982

8074

N06AB05

ATC

paroxetine; oral

1.3

7.5

516

3921

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

2.9

7.5

146

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.8

7.5

130

737

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.6

7.5

173

1062

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

7.5

513

XG430

NOMESCO Finland

Spiroegometry

2.8

7.5

160

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.5

202

1291

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

7.5

749

5978

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

7.5

1350

11442

N06BA04

ATC

methylphenidate; oral

1.4

7.5

317

2229

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

1.6

7.4

161

971

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.6

7.4

181

1129

H26.3

ICD-10 Finland

Drug-induced cataract

2.6

7.4

184

P03

ICPC

Feeling depressed

1.2

7.4

1256

10582

R19.4

ICD-10 Finland

Change in bowel habit

1.7

7.4

149

882

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.6

7.4

179

1113

M02AA07

ATC

piroxicam; topical

1.1

7.4

2555

22743

F32.1

ICD-10 Finland

Moderate depressive episode

1.3

7.4

653

5134

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.1

7.4

348

S01BC05

ATC

ketorolac; ophthalmic

1.7

7.4

157

943

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.3

7.4

275

D82

ICPC

Teeth/gum disease

1.1

7.4

4104

37597

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.3

7.4

556

4283

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

3.8

7.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.8

7.3

113

614

R09

ICPC

Sinus symptom/complaint

1.2

7.3

810

6538

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

7.3

269

1839

N61

ICD-10 Finland

Inflammatory disorders of breast

1.4

7.3

285

1974

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

7.3

475

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.6

7.2

188

1190

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.8

7.2

116

640

L40.8

ICD-10 Finland

Other psoriasis

2.4

7.2

234

R52.2

ICD-10 Finland

Other chronic pain

1.5

7.2

237

1582

CG2T4

NOMESCO Finland

Topography assessment of cornea

2.3

7.2

273

N48.1

ICD-10 Finland

Balanoposthitis

1.7

7.2

129

738

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.2

687

5452

R11

ICD-10 Finland

Nausea and vomiting

1.3

7.2

688

5462

E86

ICD-10 Finland

Volume depletion

1.9

7.2

498

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

3.3

7.2

F45.8

ICD-10 Finland

Other somatoform disorders

1.2

7.2

820

6646

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.1

601

4694

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

7.1

1151

9656

L28

ICPC

Limited function/disability (L)

1.2

7.1

816

6613

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

7.1

510

3899

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

7.1

680

5398

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.3

7.1

654

5167

L24

ICD-10 Finland

Irritant contact dermatitis

3.7

7.1

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

7.1

1853

16170

D06BB04

ATC

podophyllotoxin; topical

1.3

7.1

629

4947

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.0

7.1

451

6918X

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DERMATITIS ALIA DEFINITA SEU NUD]

19.8

7.1

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.3

7.0

411

3050

L56.9

ICD-10 Finland

Acute skin change due to ultraviolet radiation, unspecified

6.5

7.0

H81.4

ICD-10 Finland

Vertigo of central origin

2.8

7.0

149

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.4

7.0

379

2779

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

5.0

7.0

S07

ICPC

Rash generalized

2.3

7.0

260

SFA00

NOMESCO Finland

Small filling

1.2

7.0

1155

9710

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

7.0

153

926

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

7.0

1372

11708

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

2.4

7.0

215

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

7.0

711

5690

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

4.5

7.0

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

4.0

7.0

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.2

7.0

1079

9019

C08CA05

ATC

nifedipine; systemic

1.4

6.9

329

2358

R01AC07

ATC

nedocromil; nasal

2.5

6.9

198

T92.1

ICD-10 Finland

Sequelae of fracture of arm

2.5

6.9

198

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.3

6.9

399

2956

C07AA05

ATC

propranolol; systemic

1.2

6.9

1904

16681

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.2

6.9

836

6816

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.4

6.9

264

1820

A07EA06

ATC

budesonide; oral, local oral

1.4

6.9

278

1937

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.2

6.9

699

5590

A01AB04

ATC

amphotericin B; local oral

1.5

6.9

227

1519

W84

ICD-10 Finland

Unspecified threat to breathing

3.1

6.9

107

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

6.9

387

2857

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.8

1590

13756

D01BA02

ATC

terbinafine; oral; topical

1.2

6.8

1717

14941

SPAT1307

SPAT

Psychosocial counselling and guidance

1.2

6.8

982

8148

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.5

6.8

230

1547

Y0999

ICD-8 Finland

Other specific examinations and investigations

3.5

6.8

H02.1

ICD-10 Finland

Ectropion of eyelid

3.2

6.8

102

N06AX12

ATC

bupropion; oral

1.2

6.8

699

5595

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.5

6.8

204

1338

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.4

6.8

312

2227

4451

FHL

Guitar cutting

1.3

6.8

445

3361

N17

ICPC

Vertigo/dizziness

1.2

6.8

778

6310

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.1

6.8

2296

20400

SPAT1325

SPAT

Vaccination

1.1

6.8

2941

26538

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

3.6

6.7

S19

ICPC

Skin injury other

1.4

6.7

266

1844

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.2

6.7

304

M54.1

ICD-10 Finland

Radiculopathy

1.4

6.7

253

1737

D07AC06

ATC

diflucortolone; topical

9.2

6.7

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

9.2

6.7

Z94.0

ICD-10 Finland

Kidney transplant status

2.0

6.7

426

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

4.1

6.7

XCH05

NOMESCO Finland

Eye pressure longterm registration

2.5

6.7

190

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.7

321

2310

L73.2

ICD-10 Finland

Hidradenitis suppurativa

1.8

6.7

108

601

L43.9

ICD-10 Finland

Lichen planus, unspecified

1.8

6.7

108

601

D19

ICPC

Teeth/gum symptom/complaint

1.1

6.6

2888

26058

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.5

6.6

208

1378

D01AA02

ATC

natamycin; topical

1.6

6.6

156

963

D82.4

ICD-10 Finland

Hyperimmunoglobulin E [IgE] syndrome

22.3

6.6

A28

ICPC

Limited function/disability NOS

1.3

6.6

570

4469

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.6

6.6

141

850

0086X

ICD-9 Finland

Intestinal infections due to other organisms, Enteritis due to specified virus[ENTERITIS VIROSA NUD]

1.9

6.6

459

LCH96

NOMESCO Finland

Other termination of pregnancy

2.9

6.6

130

L21

ICD-10 Finland

Seborrhoeic dermatitis

1.8

6.6

107

594

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

6.6

505

3904

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.4

6.6

211

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.3

6.5

424

3200

R06AE02

ATC

7.7

6.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.3

6.5

456

3475

H26.4

ICD-10 Finland

After-cataract

1.4

6.5

270

1892

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

6.5

243

1670

D05AA

ATC

Tars

2.7

6.5

146

4224

FHL

Endonasal anthrostomy

2.0

6.5

391

F34.1

ICD-10 Finland

Dysthymia

1.4

6.5

326

2363

N03AG01

ATC

valproic acid; systemic, rectal

1.3

6.5

518

4027

TAB00

NOMESCO Finland

Lumbar puncture

1.3

6.4

374

2777

S16

ICPC

Bruise/contusion

1.5

6.4

213

1427

N05BA12

ATC

alprazolam; oral

1.2

6.4

737

5973

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

6.4

198

1306

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.3

6.4

400

2999

D10BA01

ATC

isotretinoin; oral

0.8

6.4

614

7439

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.2

6.4

692

5574

DHB50

NOMESCO Finland

Turbinoplasty

1.5

6.4

223

1513

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.7

6.4

113

647

A01

ICPC

Pain general/multiple sites

1.3

6.4

548

4294

L63.1

ICD-10 Finland

Alopecia universalis

6.1

6.4

M54

ICD-10 Finland

Dorsalgia

1.2

6.4

1018

8535

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

6.4

544

4262

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

3.5

6.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

6.4

142

869

H71

ICPC

Acute otitis media/myringitis

1.6

6.4

142

869

F70

ICPC

Conjunctivitis infectious

1.5

6.3

212

1426

J30.2

ICD-10 Finland

Other seasonal allergic rhinitis

2.6

6.3

159

SPAT1234

SPAT

Support of social functional capacity

1.4

6.3

258

1803

RS142

NOMESCO Finland

3.0

6.3

114

A01AB10

ATC

natamycin; local oral

1.5

6.3

232

1589

A08.0

ICD-10 Finland

Rotaviral enteritis

2.1

6.3

327

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.7

6.3

116

673

S91

ICPC

Psoriasis

2.2

6.3

273

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

1.7

6.3

117

678

ZXE20

NOMESCO Finland

More than three and less than five hours

1.2

6.3

887

7354

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.4

6.3

311

2254

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

6.5

6.3

D01

ICPC

Abdominal pain/cramps general

1.2

6.3

1187

10103

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.1

6.3

2567

23075

50609

ICD-8 Finland

Chronic laryngitis, Unspecified

10.9

6.2

506

Kela drug reimbursment

Allergy to cow's milk and hypersensibility to conventional formula in infants

10.9

6.2

6929A

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA NUMMULARE]

10.9

6.2

B35.3

ICD-10 Finland

Tinea pedis

1.4

6.2

276

1959

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.2

6.2

801

6578

A99

ICPC

Disease/condition unspecnature/site

1.3

6.2

557

4392

0549X

ICD-9 Finland

Herpes simplex without mention of complication

26.4

6.2

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.2

6.2

1036

8725

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

2.0

6.2

337

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.3

6.2

505

3936

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

6.2

227

1556

L29

ICPC

Musculoskeletal sympt/complt other

1.3

6.2

541

4253

R04.0

ICD-10 Finland

Epistaxis

1.4

6.1

332

2440

H13.1

ICD-10 Finland

Conjunctivitis in infectious and parasitic diseases classified elsewhere

4.7

6.1

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.3

6.1

445

3414

S97

ICPC

Chronic ulcer skin

1.4

6.1

232

1600

S01GA51

ATC

naphazoline, combinations; ophthalmic

4.0

6.1

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.1

752

6149

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.3

6.1

433

3313

H16.8

ICD-10 Finland

Other keratitis

3.1

6.1

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

2.1

6.1

284

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.8

6.1

507

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.1

296

2139

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2.6

6.1

151

H53.2

ICD-10 Finland

Diplopia

1.5

6.1

180

1181

L08

ICPC

Shoulder symptom/complaint

1.2

6.1

1334

11493

W19

ICD-10 Finland

Unspecified fall

1.2

6.1

696

5647

XCK00

NOMESCO Finland

Perimetry

1.3

6.0

357

2661

R49.01

ICD-10 Finland

Functional dysphonia

1.5

6.0

202

1357

RK120

NOMESCO Finland

3.3

6.0

WQ001

NOMESCO Finland

12.4

6.0

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.4

6.0

241

1679

F05

ICPC

Visual disturbance other

1.5

6.0

190

1263

UDC00

NOMESCO Finland

Ear microscopy

1.3

6.0

553

4376

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

6.0

307

2234

H26.02

ICD-10 Finland

Presenil cataract

1.6

6.0

140

867

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

1.7

6.0

109

628

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.1

6.0

1951

17282

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

2416

9236

2.86

307.65

1.5

1.3

u/ml

1072.5

142.5

28.78

2298

8511

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

323

344

9.38

266.14

1.2

1.1

u/ml

10.6

8.0

0.29

263

227

(3003888) Timothy IgE Ab [Units/volume] in Serum

1081

3678

3.02

230.53

1.1

u/ml

7.8

6.5

1.38

791

1973

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1159

4102

2.91

230.30

1.2

1.1

u/ml

2.6

1.7

1.52

725

1703

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1051

3547

3.04

227.27

1.1

u/ml

5.0

2.2

5.38

402

903

(3012494) Peanut IgE Ab [Units/volume] in Serum

355

549

6.46

212.39

1.2

1.1

u/ml

29.1

12.9

0.36

280

319

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1009

3511

2.94

206.20

1.1

u/ml

2.6

0.9

6.01

676

1550

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

194

165

11.66

186.86

1.0

u/ml

0.3

0.1

0.65

130

(3011841) English Walnut IgE Ab [Units/volume] in Serum

205

190

10.70

186.51

1.1

u/ml

5.4

0.01

177

143

(3011897) Casein IgE Ab [Units/volume] in Serum

256

327

7.79

182.22

1.6

1.2

u/ml

17.0

0.3

2.40

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

201

191

10.44

179.75

1.1

u/ml

4.8

2.4

0.93

170

145

(3027231) Wheat IgE Ab [Units/volume] in Serum

264

362

7.25

176.63

1.2

1.1

u/ml

1.9

2.2

—

(3013115) Eosinophils [#/volume] in Blood

8175

62412

1.61

172.85

7.1

6.3

e9/l

0.2

82.80

7325

55704

(42870588) Differential panel, method unspecified - Blood

5623

39245

1.64

171.80

6.5

6.3

—

(3006315) Basophils [#/volume] in Blood

7917

60220

1.60

168.03

6.9

6.1

e9/l

0.0

8.51

6993

52826

(3001604) Monocytes [#/volume] in Blood

7894

60016

1.60

167.79

6.9

6.1

e9/l

0.6

0.5

9.01

6978

52744

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

146

15.04

163.59

1.6

1.2

u/ml

11.3

4.9

0.61

134

(3019198) Lymphocytes [#/volume] in Blood

8129

62657

1.58

159.51

6.8

6.0

e9/l

2.0

0.18

7323

56172

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

150

111

13.36

157.32

1.0

u/ml

2.1

1.0

0.54

106

(3006504) Eosinophils/100 leukocytes in Blood

7470

56603

1.57

156.87

6.9

6.1

3.4

2.8

86.42

7064

53126

(3019069) Monocytes/100 leukocytes in Blood

7504

56938

1.57

156.51

7.1

6.4

8.3

8.1

3.05

7140

53794

(3022096) Basophils/100 leukocytes in Blood

7240

54648

1.56

153.34

6.9

6.2

0.7

3.11

6850

51316

(3018010) Neutrophils/100 leukocytes in Blood

7632

58739

1.54

144.97

6.6

5.9

55.4

55.8

2.19

7267

55509

(3002030) Lymphocytes/100 leukocytes in Blood

7715

59585

1.54

143.75

6.9

6.1

29.6

30.1

4.49

7331

56118

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

174

189

9.11

141.14

1.0

1.1

u/ml

0.9

0.03

114

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

175

192

9.02

140.86

1.0

1.1

u/ml

3.1

4.1

0.10

104

(3014133) Dog dander IgE Ab [Units/volume] in Serum

792

2982

2.69

138.44

1.1

u/ml

11.8

3.8

9.67

472

1191

(3013650) Neutrophils [#/volume] in Blood by Automated count

8643

68760

1.53

137.94

9.0

8.8

e9/l

4.0

0.21

7658

60390

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

143

126

11.22

134.57

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

156

175

8.82

123.43

1.0

1.1

u/ml

0.3

0.7

0.60

108

(3020874) Milk IgE Ab [Units/volume] in Serum

433

1257

3.44

119.18

1.3

1.1

u/ml

8.0

0.7

2.70

277

345

(3014599) Egg white IgE Ab [Units/volume] in Serum

418

1213

3.44

115.11

1.3

1.0

u/ml

10.0

4.0

0.89

269

285

(3023430) Cat dander IgE Ab [Units/volume] in Serum

707

2792

2.55

111.86

1.1

u/ml

10.5

5.5

5.54

464

1173

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

112

11.88

109.50

1.0

u/ml

29.6

11.8

2.35

(40768443) Skin Pathology biopsy report

926

4249

2.21

104.14

1.3

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

2174

13351

1.69

100.93

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

611

2403

2.55

97.36

1.1

1.0

u/ml

1.3

0.2

3.81

289

469

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4657

34332

1.47

96.34

1.4

1.3

u/ml

2.0

1.7

0.81

1216

9563

(3013707) Erythrocyte sedimentation rate by Westergren method

10121

86089

1.45

95.55

4.1

3.7

mm/h

9.8

9.4

1.99

9516

80717

(3007164) IgA [Mass/volume] in Serum or Plasma

4050

29462

1.47

88.02

1.5

1.4

g/l

2.2

2.1

3.18

2457

18645

(3036312) Salmon IgE Ab [Units/volume] in Serum

10.89

87.79

1.1

u/ml

3.6

0.9

1.68

(3021589) Normoblasts [#/volume] in Blood

6751

53946

1.40

87.27

9.3

8.5

e9/l

0.0

0.13

5532

44166

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

104

113

9.07

84.36

1.0

u/ml

4.0

0.3

1.84

(3015076) Soybean IgE Ab [Units/volume] in Serum

353

1121

3.14

83.95

1.2

1.0

u/ml

1.6

0.4

1.15

124

143

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

308

946

3.24

77.44

1.3

u/ml

1.7

0.9

1.02

130

358

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

106

132

7.92

77.13

1.0

1.1

u/ml

12.0

9.8

0.30

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

9.34

76.34

1.0

u/ml

0.9

0.4

0.62

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

188

432

4.31

72.17

1.4

u/ml

28.0

18.1

1.01

(3000494) Fungus identified in Specimen by Culture

1962

12721

1.59

71.34

1.5

1.4

—

(4010399)

1236

7108

1.77

71.25

1.5

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

103

137

7.41

70.85

1.1

u/ml

1.4

0.5

2.07

(40758558) Short blood count panel - Blood

3908

29239

1.42

69.86

6.6

6.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

163

368

4.38

64.05

1.3

titre

31.2

71.0

1.69

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

216

601

3.56

63.51

1.1

1.0

u/ml

13.1

7.6

1.19

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

164

380

4.26

62.33

1.3

titre

772.9

548.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

247

765

3.20

61.31

1.3

1.5

ug/l

5.3

7.0

2.13

223

684

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9593

83683

1.33

59.24

7.2

6.7

u/l

77.6

75.7

3.30

9107

79023

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13513

124972

1.50

55.39

12.9

10.7

mg/l

19.9

20.5

1.53

10628

95181

(36660697) Celiac disease serology panel - Serum

1825

12281

1.52

55.12

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

2515

18068

1.44

54.41

1.5

1.4

titre

496.9

552.5

0.75

497

3418

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5827

47865

1.31

53.35

2.5

2.3

nmol/l

73.9

1910.3

0.50

5452

44636

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3554

27184

1.37

52.95

2.4

2.2

mg/l

2.6

2.7

2.60

3043

23490

(3000492) Spirometry study

1798

12253

1.50

50.82

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

104

202

5.07

49.08

1.1

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

2603

19241

1.39

47.10

2.9

2.6

ug/g

127.0

114.7

0.86

2058

15190

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10974

99123

1.30

43.75

4.3

4.0

pmol/l

14.4

2.42

10182

91791

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5252

43372

1.28

43.48

6.1

mmol/l

1.2

0.15

4845

39813

(3018001) Oat IgE Ab [Units/volume] in Serum

114

6.30

43.38

1.1

1.0

u/ml

1.9

0.5

0.41

(3042936) Bacteria identified in Isolate by Culture

1973

14146

1.42

42.16

2.1

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12400

114116

1.34

41.79

5.0

4.6

mu/l

2.2

2.1

0.17

11709

107623

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7292

62917

1.26

41.17

3.2

2.9

ug/l

83.3

82.8

0.09

6893

59609

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

243

938

2.56

40.30

2.1

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

714

4118

1.73

40.24

1.8

1.9

g/l

1.2

0.18

680

3941

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

694

3990

1.74

39.55

1.8

1.9

g/l

0.2

0.01

658

3810

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4618

37985

1.27

38.18

1.9

1.8

pmol/l

97.0

98.2

1.09

2571

20611

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5696

48126

1.25

37.27

6.5

mmol/l

1.2

0.02

4887

41035

(3019550) Sodium [Moles/volume] in Serum or Plasma

12805

118854

1.34

37.23

12.7

11.0

mmol/l

139.5

139.6

7.26

12480

115563

(3023368) Bacteria identified in Blood by Culture

2998

23380

1.32

37.12

4.5

4.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

12837

119227

1.34

36.90

12.8

11.1

mmol/l

3.9

2.71

12482

115627

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2684

20753

1.32

35.06

1.3

u/ml

8.5

9.5

0.31

1038

8637

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4639

38478

1.26

35.03

1.9

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2806

21912

1.31

34.02

1.3

iu/ml

23.6

29.1

1.08

828

6603

(3002385) Erythrocyte distribution width [Ratio]

11856

109241

1.28

33.97

15.3

13.0

13.4

0.24

11659

107076

(3020961) Endomysium IgA Ab [Titer] in Serum

1186

8058

1.48

33.35

1.2

1.1

titre

196.7

238.2

0.28

225

(3022948) Iron [Moles/volume] in Serum or Plasma

2104

15810

1.35

33.19

2.5

2.4

umol/l

14.3

14.4

0.06

1979

14789

(3024561) Albumin [Mass/volume] in Serum or Plasma

5028

42299

1.25

33.03

5.1

4.8

g/l

36.6

36.8

1.20

4724

39479

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6202

53568

1.23

31.29

5.4

5.6

umol/l

11.0

10.8

0.50

5825

50364

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1757

13009

1.37

30.29

2.6

2.5

23.8

23.9

0.12

1551

11349

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

164

606

2.67

29.83

1.0

—

(3018418) pH of Serum or Plasma

3429

27952

1.26

28.93

4.0

3.8

7.4

0.97

651

5383

(3026493) Urate [Moles/volume] in Serum or Plasma

3140

25333

1.27

28.90

2.5

2.3

umol/l

2573.8

2726.2

0.10

2799

22708

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1897

14336

1.34

28.48

2.5

2.4

g/l

2.4

2.5

0.83

1774

13360

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

284

3.43

28.02

1.6

ug/l

8.5

9.0

0.51

284

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

221

3.78

27.84

1.1

u/ml

0.0

0.27

131

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

916

6138

1.49

27.48

1.1

u/ml

1.1

14.7

1.40

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3210

26152

1.26

26.91

1.8

1.9

mg/l

1.0

0.13

2319

19184

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13751

130077

1.35

26.69

10.0

8.6

u/l

26.6

26.3

0.86

13412

126273

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1576

11692

1.36

26.63

2.2

2.1

nmol/l

364.7

376.2

1.47

1453

10796

(3015377) Calcium [Moles/volume] in Serum or Plasma

3982

33266

1.23

26.53

2.9

3.1

mmol/l

2.3

2.4

2.15

3513

29840

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13617

128699

1.33

25.96

13.4

11.3

umol/l

69.8

70.2

1.01

13608

128643

(3005719) IgG [Mass/volume] in Serum or Plasma

1300

9389

1.39

25.93

2.8

2.7

g/l

10.5

10.4

0.20

1207

8647

(3021960) Folate [Moles/volume] in Serum or Plasma

2580

20567

1.28

25.83

1.5

nmol/l

20.2

20.3

0.24

2280

18237

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1985

15313

1.31

25.58

4.0

4.1

mmol/l

0.8

0.04

1828

14433

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11803

109685

1.24

25.57

11.0

9.1

ml/min/173m2

93.9

93.1

4.28

9568

88139

(40760892) CBC W Ordered Manual Differential panel - Blood

3582

29755

1.23

24.88

4.9

4.1

—

(40761511) CBC panel - Blood by Automated count

13902

131906

1.35

24.85

11.4

9.8

—

(40768797) Stomach Pathology biopsy report

1826

14004

1.32

24.48

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

3319

27413

1.24

24.21

3.9

4.0

94.9

94.5

0.34

3239

26651

(3028026) IgM [Mass/volume] in Serum or Plasma

1030

7236

1.42

24.07

1.8

g/l

1.2

1.3

1.20

969

6729

(3013826) Glucose [Moles/volume] in Serum or Plasma

7061

62783

1.19

23.64

4.6

4.5

mmol/l

6.3

6.4

1.11

6432

56938

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3325

27534

1.23

23.58

2.1

u/l

173.3

205.2

1.65

3152

26085

(3031040) Bacteria [#/volume] in Urine by Automated count

8666

78520

1.19

23.09

4.3

3.9

e6/l

1446.4

1287.1

0.12

108

952

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

898

6200

1.45

23.07

5.1

4.9

mmol/l

1.0

1.3

1.45

646

4409

(3007542) Rye IgE Ab [Units/volume] in Serum

5.19

22.97

1.1

1.0

u/ml

29.3

0.3

0.51

(3007461) Platelets [#/volume] in Blood

14786

142019

1.56

22.94

18.8

15.7

e9/l

268.1

261.6

30.46

14494

138821

(3009343) pH of Capillary blood

917

6368

1.44

22.83

5.1

4.9

7.4

0.45

707

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

438

2584

1.68

22.76

1.2

1.3

u/ml

5.4

4.0

0.16

189

(3027945) Reticulocytes/100 erythrocytes in Blood

1257

9217

1.37

22.75

3.2

3.1

1.7

0.15

1131

8313

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

923

6431

1.43

22.56

5.1

4.9

kpa

5.1

0.39

862

6042

(36304419) Bacteria [Presence] in Urine

3455

28869

1.22

22.26

3.1

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

9087

82802

1.19

22.22

4.3

3.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

127

482

2.60

22.03

1.2

109.8

108.7

0.18

114

437

(3024731) MCV [Entitic volume]

14792

142171

1.55

21.89

18.7

15.6

89.8

1.14

14673

140650

(3000963) Hemoglobin [Mass/volume] in Blood

14800

142265

1.55

21.89

18.9

15.8

g/l

135.6

135.9

1.72

14685

140741

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

571

3632

1.56

21.84

1.2

1.3

u/ml

19.9

34.9

1.12

235

(3026361) Erythrocytes [#/volume] in Blood

14794

142199

1.55

21.83

18.7

15.7

e12/l

4.5

4.6

2.08

14479

138767

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1879

14675

1.29

21.83

1.8

—

(3035941) MCH [Entitic mass]

14791

142165

1.55

21.82

18.7

15.6

30.0

0.95

14673

140645

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1645

12625

1.31

21.80

6.7

6.6

mmol/l

1.1

2.47

1551

11893

(3002179) Metamyelocytes/100 leukocytes in Blood

1135

8252

1.38

21.64

4.2

4.0

0.5

0.15

218

1620

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

670

4423

1.51

21.60

5.7

5.3

mmol/l

24.2

24.5

1.71

641

4235

(3010813) Leukocytes [#/volume] in Blood

14796

142251

1.54

21.47

18.8

15.7

e9/l

6.9

6.7

4.72

14490

138779

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

527

3305

1.58

21.44

1.3

u/ml

20.5

9.8

1.00

503

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

963

6823

1.41

21.42

1.8

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

652

4289

1.51

21.38

1.4

1.6

u/ml

3.4

10.6

3.83

147

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3935

33433

1.21

21.20

2.8

2.5

u/l

55.9

57.0

0.53

3648

30981

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11578

107976

1.21

21.10

4.0

3.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1316

9831

1.34

21.05

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

3745

31693

1.21

20.99

3.3

3.0

e6/l

65.2

75.4

0.23

2862

23714

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

455

2772

1.63

20.89

1.5

iu/ml

18.5

11.2

0.41

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1296

9681

1.34

20.73

1.7

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1213

8972

1.35

20.71

4.5

4.3

0.8

0.05

290

2207

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

419

2510

1.65

20.57

1.3

1.2

u/ml

20.5

14.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1167

8591

1.36

20.54

4.6

4.4

0.1

0.51

271

2061

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

516

3256

1.57

20.46

1.3

u/ml

5.5

9.1

0.71

329

(3019309) Folate [Moles/volume] in Red Blood Cells

1848

14528

1.28

20.29

1.7

nmol/l

1143.5

1171.6

0.69

1429

11384

(3030467) Casts [#/volume] in Urine by Automated count

3427

28856

1.21

20.09

3.2

2.9

e6/l

0.3

1.38

2558

21173

(3007700) Barley IgE Ab [Units/volume] in Serum

5.03

19.87

1.1

1.0

u/ml

22.4

0.3

0.52

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4605

39872

1.19

19.86

3.2

u/l

31.9

31.6

0.07

4388

38038

(3025159) Blasts/100 leukocytes in Blood

1118

8221

1.36

19.81

4.6

4.4

0.4

0.1

0.37

233

1755

(3018095) Leukocytes [#/volume] in Urine

4531

39266

1.19

19.18

3.8

3.4

e6/l

63.1

71.4

0.53

3114

25984

(3000991) Gas panel - Venous blood

1112

8215

1.35

19.11

8.1

9.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

130

538

2.38

18.84

1.2

g/l

0.3

0.58

105

435

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

787

5516

1.42

18.60

4.8

5.9

mmol/l

23.8

24.0

1.36

723

5092

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.55

18.51

1.7

1.3

—

(3022313) Gas panel - Capillary blood

692

4747

1.45

18.40

5.5

5.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

756

5281

1.42

18.21

1.3

u/ml

1.0

0.06

424

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

635

4304

1.47

17.98

1.7

1.6

iu/ml

28.9

0.4

0.50

117

894

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

278

1552

1.77

17.72

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1049

7800

1.34

17.24

6.6

8.2

mmol/l

1.3

0.08

1003

7491

(3000850) Epithelial cells [#/volume] in Urine

2618

21776

1.21

17.03

2.7

2.5

e6/l

6.6

7.3

1.63

2281

18963

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

534

3540

1.50

16.92

1.6

titre

438.2

335.0

0.18

144

(3009542) Hematocrit [Volume Fraction] of Blood

12930

122517

1.22

16.79

13.5

11.5

40.2

0.10

10661

100405

(3003327) Ova and parasites identified in Stool by Light microscopy

754

5347

1.40

16.68

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1200

9148

1.31

16.55

2.8

2.6

g/l

0.2

0.08

1121

8577

(3004588) Protein electrophoresis panel - Serum or Plasma

647

4473

1.44

16.52

1.9

2.1

—

(3026782) Osmolality of Urine

2431

20141

1.22

16.40

2.8

2.6

mosm/kgh2o

547.5

549.0

0.11

2049

17175

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

595

4063

1.45

16.23

1.9

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

991

7407

1.33

15.72

4.0

4.8

kpa

4.9

4.8

0.38

947

7183

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2093

17149

1.23

15.70

2.8

2.5

e6/l

1.0

1.1

0.17

1166

9245

(3023520) Reticulocytes [#/volume] in Blood

874

6417

1.36

15.62

2.7

2.9

e9/l

70.7

70.6

0.03

629

4631

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9453

87530

1.15

15.37

3.1

2.9

u/l

38.9

37.8

0.81

8988

83588

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

647

4540

1.41

15.23

1.1

u/ml

4.2

5.2

0.40

693

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10639

99391

1.16

15.21

4.6

4.3

mmol/mol

37.7

37.8

0.38

10049

94030

(3020630) Protein [Mass/volume] in Serum or Plasma

811

5910

1.36

15.21

2.2

2.4

g/l

67.2

67.1

0.12

758

5497

(3028626) Oxygen [Partial pressure] in Capillary blood

487

3243

1.49

15.13

6.4

6.1

kpa

9.2

0.14

454

3073

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3846

33415

1.17

15.00

3.0

2.7

ng/l

28.1

65.7

1.14

1877

16370

(3022145) Colonoscopy Study observation

1488

11811

1.26

14.87

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

325

1990

1.61

14.74

1.8

2.0

g/l

38.2

38.7

0.67

287

1765

(3009261) Glucose [Presence] in Urine by Test strip

6657

60265

1.15

14.72

3.5

3.2

estimate

0.0

0.49

1320

11690

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1491

11868

1.26

14.53

1.2

iu/ml

123.1

147.2

1.54

536

4537

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

884

6588

1.33

14.30

4.4

4.3

ng/l

77.2

79.0

0.26

792

5926

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1141

8824

1.29

14.09

4.6

5.2

kpa

5.9

5.8

0.59

1097

8560

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

348

2190

1.57

14.08

2.0

2.1

g/l

0.4

0.7

1.51

308

1951

(3045683) HLA typing for celiac disease panel - Blood or Tissue

196

1059

1.82

14.04

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

333

2077

1.58

14.01

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

333

2078

1.58

13.98

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11677

110081

1.17

13.98

3.8

3.5

mmol/l

5.6

5.7

1.32

10952

103013

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3146

27030

1.18

13.93

1.6

mmol/l

1.4

0.84

2783

23538

(44813793)

212

1180

1.77

13.77

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

241

1392

1.71

13.74

1.4

g/l

7.0

6.6

0.63

184

978

(3028192) IgG subclass 2 [Mass/volume] in Serum

241

1392

1.71

13.74

1.4

g/l

2.8

2.9

0.28

184

977

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

9.81

13.69

1.0

u/ml

1.6

10.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

296

1806

1.62

13.66

1.9

2.0

g/l

0.0

0.00

277

1680

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1560

12567

1.24

13.63

2.8

3.0

umol/l

7.6

6.7

0.85

1335

10696

(4062490)

241

1395

1.70

13.63

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

6593

59852

1.14

13.57

4.7

4.4

estimate

0.0

0.18

1364

11984

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1246

9787

1.27

13.57

4.0

4.3

u/l

242.8

235.0

0.52

1192

9318

(3024139) IgG subclass 3 [Mass/volume] in Serum

240

1393

1.70

13.45

1.4

g/l

0.4

0.42

183

979

(3035350) Ketones [Presence] in Urine by Test strip

6576

59716

1.14

13.42

3.5

3.2

estimate

0.0

1.91

1313

11528

(3002032) Base excess in Venous blood by calculation

1130

8788

1.28

13.34

4.6

5.2

mmol/l

1.4

1.7

1.96

920

7072

(3020779) Urea [Moles/volume] in Serum or Plasma

1021

7840

1.30

13.31

8.8

8.7

mmol/l

7.7

7.6

0.17

993

7546

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

296

1822

1.60

13.19

1.9

2.0

g/l

0.0

0.36

277

1683

(3017143) Hepatitis C virus Ab [Presence] in Serum

2506

21211

1.19

13.16

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.14

13.16

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

340

2166

1.55

13.07

1.5

1.6

g/l

0.7

0.22

275

1659

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

193

1064

1.79

12.98

1.1

iu/ml

5.3

7.2

0.74

280

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1301

10329

1.26

12.93

2.6

2.5

u/l

33.7

40.8

0.82

1120

8887

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1966

16301

1.21

12.93

2.9

2.7

e6/l

3.6

3.8

0.31

1054

8407

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

636

4582

1.38

12.85

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

318

2.47

12.81

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

143

723

1.95

12.62

1.1

u/ml

18.5

10.3

1.48

122

(3039162) Centromere protein B Ab [Units/volume] in Serum

274

1676

1.61

12.56

1.2

1.3

u/ml

30.5

51.4

0.79

103

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

317

2007

1.56

12.55

1.9

2.0

g/l

0.0

0.30

298

1862

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1916

15920

1.21

12.28

2.6

mmol/l

2.4

0.89

1626

13874

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

361

2368

1.51

12.16

1.9

2.1

g/l

10.2

10.3

0.18

312

2036

(3023420) DNA double strand Ab [Units/volume] in Serum

243

1457

1.64

12.08

1.4

1.7

iu/ml

24.1

34.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

101

457

2.17

12.04

1.6

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

181

1003

1.78

12.00

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

586

4214

1.38

11.99

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3127

27131

1.16

11.99

3.4

3.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

652

4770

1.35

11.97

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

154

813

1.87

11.96

1.3

1.2

u/ml

38.3

55.8

—

(3032080) INR in Blood by Coagulation assay

3944

34809

1.15

11.95

6.4

6.1

inr

1.1

1.84

1283

11381

(3044889) 12 lead EKG panel

7877

72664

1.13

11.92

3.1

2.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

369

2446

1.49

11.82

1.9

2.1

g/l

3.0

0.02

299

1939

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

383

2559

1.48

11.80

1.8

2.0

g/l

7.1

7.2

0.49

303

1975

(3035947) Staphylolysin Ab [Units/volume] in Serum

105

487

2.12

11.77

1.2

1.1

iu/ml

4.5

3.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

189

1068

1.74

11.73

2.6

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

382

2556

1.48

11.68

1.8

2.0

g/l

3.9

3.7

1.14

295

1868

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

382

2556

1.48

11.68

1.8

2.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

153

817

1.84

11.48

1.3

1.2

u/ml

38.3

48.5

0.25

(3038026) Centromere Ab [Units/volume] in Serum

155

832

1.83

11.44

1.3

1.2

u/ml

42.1

43.5

—

(3004616) Nuclear Ab [Presence] in Serum

230

1385

1.64

11.28

1.4

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2188

18559

1.18

11.05

2.9

ng/l

1069.8

906.7

0.61

1737

15201

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1144

9111

1.25

11.05

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

147

786

1.84

11.01

1.3

1.2

u/ml

10.5

11.7

0.06

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

371

2500

1.47

10.98

4.0

3.7

55.6

56.6

0.99

371

2500

(3017958) Strawberry IgE Ab [Units/volume] in Serum

5.01

10.92

1.0

u/ml

0.4

0.1

0.43

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

152

2.97

10.58

1.7

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

420

2919

1.42

10.55

1.2

1.3

u/ml

37.1

40.3

0.17

265

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

127

658

1.90

10.51

3.9

4.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1109

8861

1.24

10.40

2.4

2.3

au/ml

22.5

21.5

0.14

668

(3024891) Influenza virus A+B Ag [Presence] in Specimen

534

3875

1.36

10.38

1.1

—

(3044941) Cell count panel - Synovial fluid

217

1321

1.62

10.24

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

189

1111

1.68

10.22

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2313

19832

1.17

10.17

1.6

pmol/l

30448350.1

31782560.0

0.04

1987

17148

(46235355) HIV 1 and 2 tests - Meaningful Use set

4743

42718

1.13

10.16

2.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1115

1.67

10.09

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

3592

31807

1.14

10.07

3.9

3.5

estimate

0.0

0.33

1322

11674

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

121

3.16

9.99

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

8.50

9.98

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1028

8187

1.25

9.94

1.3

au/ml

56.2

44.2

0.70

303

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

185

2.71

9.92

1.5

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1113

1.66

9.92

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1127

1.65

9.71

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

300

1991

1.49

9.64

1.5

1.7

e6/l

8864.8

12040.5

1.13

206

1470

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1125

1.65

9.53

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1126

1.64

9.50

1.2

—

(3011412) CD3 cells [#/volume] in Blood

221

1377

1.58

9.50

2.6

e9/l

1.4

1.3

0.63

145

830

(3047007) Chlamydophila sp Ab [Presence] in Serum

349

2393

1.44

9.49

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

243

1552

1.54

9.38

1.6

—

(3025941) Bacteria identified in Stool by Culture

998

7982

1.24

9.29

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1980

16891

1.17

9.23

3.4

3.1

ng/l

337.7

515.2

0.87

1216

9962

(3023419) Bacteria identified in Sputum by Culture

158

914

1.70

9.13

3.2

2.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

252

1636

1.52

9.04

1.1

g/l

1.5

0.58

236

1495

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2269

19611

1.16

8.90

1.8

1.7

1.4

1.94

2037

17761

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1708

14439

1.18

8.89

2.3

2.6

29.9

29.6

1.30

1655

14008

(3009508) Creatinine [Moles/volume] in Urine

3367

29897

1.13

8.87

3.5

3.3

mmol/l

8.2

0.05

2911

26047

(21494815) CD4 cells/100 lymphocytes in Specimen

199

1232

1.59

8.83

2.5

44.0

0.00

152

(3000570) Elastase.pancreatic [Mass/mass] in Stool

398

2834

1.39

8.76

1.4

ug/g

311.6

298.1

0.59

211

1506

(3021661) Pineapple IgE Ab [Units/volume] in Serum

6.13

8.75

1.0

u/ml

0.3

0.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

643

4931

1.29

8.55

1.6

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

419

3023

1.37

8.52

1.9

2.1

mg/l

11.2

10.2

0.80

392

2853

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

186

1147

1.60

8.41

2.6

2.4

11.0

12.1

0.84

121

675

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

628

4813

1.29

8.40

1.9

2.0

u/l

40.0

39.5

0.29

577

4447

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

175

1065

1.62

8.36

2.4

2.8

e9/l

0.2

0.01

146

874

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

124

688

1.77

8.34

2.9

3.0

au/ml

145.4

138.7

0.06

107

(3048929) Epstein Barr virus Ab [Presence] in Serum

888

7101

1.24

8.30

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

507

1.90

8.25

1.2

—

(40768804) Tissue Pathology biopsy report

5090

46453

1.11

8.19

2.0

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

382

2735

1.38

8.17

1.7

1.6

—

(3003338) MCHC [Mass/volume]

12014

114605

1.13

8.13

15.8

13.3

g/l

333.3

0.21

11932

113734

(3007566) Smooth muscle Ab [Titer] in Serum

472

3509

1.33

7.91

1.3

1.4

titre

90.0

116.8

0.69

364

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

334

2353

1.40

7.88

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1006

8199

1.22

7.84

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

501

3768

1.31

7.74

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

497

3735

1.31

7.72

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

305

2123

1.42

7.72

1.3

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

174

1082

1.58

7.64

2.4

2.8

e6/l

537.1

537.9

0.01

141

875

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

129

745

1.70

7.59

4.0

3.6

mg/l

8.2

8.3

0.11

100

596

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.96

7.54

1.0

u/ml

2.6

0.3

0.85

(42529406) Shigella sp [Presence] in Stool by Culture

501

3789

1.31

7.45

1.3

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

231

1538

1.48

7.42

2.8

2.7

nmol/l

23.1

22.1

0.54

220

1477

(3017732) Neutrophils [#/volume] in Blood

1041

8574

1.20

7.29

2.1

2.4

e9/l

4.2

0.17

854

7186

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

322

2288

1.39

7.26

1.7

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1257

10536

1.18

7.24

7.4

7.6

mmol/l

104.6

104.8

0.73

1234

10342

(3034770) Mitochondria Ab [Titer] in Serum

456

3419

1.32

7.23

1.3

titre

1515.0

972.6

0.56

(3000060) B lymphocytes [#/volume] in Blood

109

610

1.76

7.19

2.4

2.7

e6/l

279.2

249.2

0.35

350

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

241

1630

1.46

7.16

1.7

1.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

176

2.45

7.14

1.7

mg/l

1.2

1.9

0.58

118

(3028433) Virus identified in Specimen by Culture

394

1.94

7.11

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12082

115527

1.12

7.07

4.0

3.8

mmol/l

2.8

2.9

1.89

11418

109147

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

3.6

4.1

0.19

106

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

1.8

1.7

0.06

107

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

0.8

1.1

0.41

119

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

3.5

3.0

0.19

114

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

0.9

1.3

0.43

107

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

3.1

2.6

0.19

118

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

1.7

2.5

0.59

111

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

171

2.47

7.06

1.7

mg/l

1.4

2.4

0.90

124

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

486

3691

1.30

7.03

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

322

2304

1.38

6.98

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

326

2338

1.37

6.97

1.6

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

369

2699

1.35

6.96

1.2

1.1

au/ml

9.2

11.3

0.43

195

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

262

1811

1.43

6.95

1.2

—

202.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

116

2.79

6.91

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1112

9274

1.19

6.79

3.1

2.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1470

12544

1.16

6.79

2.4

2.3

u/l

6977.0

6395.5

0.23

580

4910

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

4.11

6.79

1.0

u/ml

3.5

0.2

0.65

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

461

3494

1.30

6.78

1.4

u/ml

227.4

244.4

0.77

277

2189

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

212

2.27

6.70

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

201

1332

1.49

6.66

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

156

980

1.57

6.63

2.4

2.9

e6/l

817.2

828.8

0.05

365

(3007456) Orange IgE Ab [Units/volume] in Serum

4.01

6.59

1.1

1.0

u/ml

0.1

0.19

(3029075) Extractable nuclear Ab panel - Serum

440

1.85

6.58

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

131

791

1.63

6.57

2.8

2.4

umol/l

1.9

1.8

0.81

122

746

(3026389) Candida sp identified in Specimen by Organism specific culture

275

1949

1.39

6.36

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1072

8988

1.18

6.17

7.1

8.0

kpa

5.1

0.04

1030

8599

(3003396) Base excess in Arterial blood by calculation

1073

9001

1.18

6.14

7.1

8.0

mmol/l

0.7

0.8

0.40

865

6861

(3027801) Oxygen [Partial pressure] in Arterial blood

1071

8983

1.18

6.14

7.1

8.0

kpa

12.8

13.5

3.47

1027

8593

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

432

3299

1.29

6.05

1.4

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

536

4204

1.26

6.05

9.4

11.0

mmol/l

24.1

0.10

512

3979

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11887

113828

1.10

5.97

3.7

3.5

mmol/l

1.5

3.06

11271

108011

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

324

2387

1.34

5.89

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

167

1095

1.50

5.89

1.6

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1239

10552

1.16

5.88

1.4

iu/l

22.3

23.2

0.50

1056

9012

(3026008) Bacteria identified in Urine by Culture

3477

31558

1.10

5.86

2.7

2.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

102

596

1.68

5.85

2.3

ug/l

25.1

111.1

1.03

562

(40761535) Cells panel - Urine sediment

923

7678

1.19

5.84

3.7

3.2

—

(3028707) Methadone [Presence] in Urine by Screen method

594

4742

1.24

5.74

2.8

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

352

2636

1.32

5.73

1.1

—

(3019150) Specific gravity of Urine by Refractometry

2927

26365

1.11

5.72

3.7

3.3

kg/l

1.0

0.03

438

3888

(3016502) Oxygen saturation in Arterial blood

949

7931

1.18

5.70

7.6

8.6

95.9

96.2

0.71

915

7628

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

346

2588

1.32

5.68

1.1

u/ml

3.8

3.0

0.50

154

1340

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1065

8990

1.17

5.67

3.0

3.4

pmol/l

4.6

0.42

943

8126

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11959

114649

1.10

5.59

3.8

3.5

mmol/l

4.7

3.32

11395

109022

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

552

4392

1.24

5.52

2.3

—

(3011985) Renin [Units/volume] in Plasma

210

1459

1.42

5.51

1.6

1.7

mu/l

80.4

64.1

0.40

192

1330

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

100

592

1.66

5.49

1.1

1.2

116.7

108.5

1.39

527

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

196

1346

1.43

5.49

1.4

1.5

pmol/l

325.9

378.5

0.80

149

1066

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

933

7813

1.18

5.48

2.5

2.4

ml/min/173m2

74.6

76.7

0.67

349

2831

(3021387) Prolactin [Units/volume] in Serum or Plasma

1032

8717

1.17

5.46

1.6

mu/l

306.2

319.1

0.59

926

7792

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

707

5781

1.21

5.42

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3369

30639

1.10

5.39

2.3

2.2

—

(3021788) Differential panel - Synovial fluid

222

1565

1.40

5.37

1.4

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

250

1802

1.37

5.29

2.7

3.1

mg/l

49.2

80.0

0.47

193

1452

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

333

2506

1.31

5.27

6.3

6.2

iu/ml

1267.5

821.9

0.20

311

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

152

1003

1.49

5.25

2.4

2.8

97.3

96.6

0.09

142

925

(3008898) HLA-B27 [Presence]

754

6225

1.20

5.22

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

243

1751

1.37

5.16

2.7

3.1

ratio

1.1

2.2

—

185

(3002523) Influenza virus A Ag [Presence] in Specimen

398

3076

1.28

5.14

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

799

6644

1.19

5.11

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

582

6889

0.82

5.09

1.5

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

3.77

5.09

1.0

1.1

u/ml

0.4

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

139

907

1.51

5.08

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

397

3073

1.27

5.07

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

472

1.71

5.03

2.2

1.8

au/ml

156.3

154.3

—

(3005033) Fetal Nuchal fold Thickness US

582

6881

0.82

5.03

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

1617

1.38

5.03

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

288

2139

1.33

5.02

2.1

g/l

135.2

132.6

1.05

203

1625

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3753

34402

1.09

5.01

1.8

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2500

22480

1.11

5.00

1.5

—

(42870560) Thyrotropin [Units/volume] in Cord blood

365

1.80

4.97

1.0

mu/l

8.5

8.7

0.12

304

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

474

1.70

4.96

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1524

13329

1.13

4.96

1.5

—

(3008295) Osmolality of Serum or Plasma

153

1024

1.47

4.95

1.6

1.9

mosm/kgh2o

283.5

284.0

0.09

110

819

(3002173) Hemoglobin [Mass/volume] in Arterial blood

883

7436

1.17

4.88

7.7

8.8

g/l

122.8

123.2

0.21

856

7165

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

247

1804

1.35

4.84

2.7

3.1

mg/l

55.5

44.5

0.19

193

1457

(3034274) Bile acid [Moles/volume] in Serum --fasting

476

3785

1.24

4.84

2.2

2.4

umol/l

5.5

5.8

0.39

360

2797

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

222

1595

1.37

4.84

1.2

—

(1002224) Polysomnography panel

699

5777

1.19

4.82

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

236

1714

1.35

4.80

1.5

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

601

7049

0.83

4.80

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

334

2550

1.29

4.78

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

153

2.24

4.77

1.1

u/ml

12.2

37.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

153

2.24

4.77

1.1

u/ml

17.1

27.7

—

(3052851) Hemolysis interference index of Serum or Plasma

395

3081

1.26

4.76

2.8

2.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

423

3327

1.25

4.75

1.5

—

(3037756) Immunofixation for Serum or Plasma

169

1163

1.43

4.74

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1401

15377

0.88

4.71

1.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

565

1.62

4.68

1.1

1.2

97.9

94.5

0.48

252

(3001964) Herpes simplex virus Ag [Presence] in Specimen

409

1.73

4.67

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1051

9003

1.15

4.66

17.6

15.4

inr

1.2

1.05

128

1492

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

373

2900

1.27

4.63

2.5

ug/l

374.3

530.5

0.65

325

2642

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

312

2372

1.30

4.63

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

748

6246

1.18

4.60

1.5

1.4

u/l

9.3

9.1

0.14

590

5072

(40768446) Kidney Pathology biopsy report

500

1.65

4.59

1.8

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

304

1.84

4.56

1.1

1.0

kpa

3.9

3.4

0.60

256

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

418

3300

1.25

4.56

1.5

u/ml

29.9

21.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

155

1059

1.44

4.54

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

749

8569

0.85

4.51

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

439

3489

1.24

4.51

6.9

7.0

mg/l

1.3

0.82

422

3317

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

744

8515

0.85

4.50

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

123

805

1.50

4.49

1.9

1.7

117.6

125.6

0.90

115

759

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

749

8564

0.85

4.48

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

358

2782

1.27

4.48

1.4

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3663

33686

1.09

4.47

2.4

2.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

476

3822

1.23

4.45

3.2

4.3

0.7

0.14

462

3679

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

396

3122

1.25

4.39

1.5

u/ml

104.4

107.1

0.24

631

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

418

3317

1.24

4.37

1.4

1.5

mg/l

442.5

460.8

0.27

402

3170

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

749

8542

0.85

4.35

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

153

1055

1.43

4.29

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

445

3563

1.23

4.29

2.4

1.9

g/l

1.4

0.70

386

3100

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1274

11123

1.13

4.29

6.0

5.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

435

1.67

4.27

1.9

1.7

nmol/l

0.2

1.00

321

(3011288) Drugs identified in Urine by Screen method

895

7633

1.16

4.24

2.9

2.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

466

1.64

4.23

2.1

2.8

umol/l

65.4

69.0

0.06

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

312

1.79

4.23

1.1

1.0

kpa

6.9

7.2

0.60

266

(3004959) Base excess in Arterial cord blood by calculation

312

1.79

4.23

1.0

mmol/l

-4.4

-1.6

1.07

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

191

1372

1.37

4.22

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.03

4.20

1.0

1.1

—

(3006598) pH of Arterial cord blood

313

1.79

4.19

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

1170

10176

1.14

4.18

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

206

1500

1.35

4.18

1.6

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

154

1069

1.42

4.17

6.1

7.4

mg/l

10.8

10.7

0.04

147

999

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5020

46849

1.07

4.13

3.6

3.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11424

109713

1.08

4.13

3.4

3.2

mmol/l

1.3

1.2

2.43

10819

103884

(3045414) Leukocytes [Presence] in Urine

615

5103

1.19

4.11

1.8

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

813

9164

0.86

4.07

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

505

4123

1.21

4.03

2.6

3.1

163.0

170.0

1.24

469

3920

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

611

1.54

4.03

2.9

2.1

mg/l

10.0

9.5

0.48

497

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

1927

1.30

4.02

3.8

4.1

u/ml

4055.6

864.1

0.55

110

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

208

1529

1.34

3.99

1.2

nmol/l

0.5

0.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

1071

1.40

3.98

1.3

titre

236.0

225.2

0.05

211

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

613

1.54

3.97

1.5

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

582

1.55

3.97

1.0

1.1

96.8

94.7

0.36

255

(3019225) pH of Specimen

985

8505

1.14

3.94

3.8

3.7

—

(3000764) Benzodiazepines [Presence] in Urine

1250

10971

1.13

3.88

2.1

—

(3027008) Opiates [Presence] in Urine

1257

11050

1.13

3.81

2.1

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1869

16789

1.10

3.80

2.0

1.9

—

(3003181) Sodium [Moles/volume] in Urine

180

1305

1.36

3.80

1.6

1.8

mmol/l

60.9

68.9

1.51

135

1044

(3012516) Albumin [Mass/volume] in Urine

2516

22921

1.09

3.78

3.6

3.4

mg/l

421.2

445.6

0.09

1644

14852

(3028300) Cannabinoids [Presence] in Urine

1259

11076

1.12

3.77

2.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

1224

1.37

3.75

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

173

1250

1.36

3.74

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

490

1.58

3.74

1.8

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

105

694

1.49

3.72

1.5

u/l

5.6

6.0

0.42

591

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

362

1.68

3.72

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

195

1438

1.33

3.69

1.1

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

187

1372

1.34

3.67

2.6

3.2

—

(1761868) Lipid panel - Serum or Plasma

4658

47811

0.94

3.56

2.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

208

1.89

3.54

3.6

4.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2615

23936

1.09

3.51

4.4

4.1

mg/mmol

12.0

10.6

0.43

1696

15715

(3017446) Testosterone [Moles/volume] in Serum or Plasma

934

8111

1.14

3.47

2.2

2.1

nmol/l

11.4

11.3

0.06

829

7234

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

164

1191

1.35

3.46

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

204

1530

1.31

3.46

1.2

nmol/l

0.5

1.3

0.52

197

1478

(3025468) Yersinia sp identified in Specimen by Organism specific culture

175

1284

1.34

3.46

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

340

1.67

3.46

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

247

1901

1.28

3.44

2.7

2.3

17.5

17.1

0.76

132

937

(3012501) Base excess in Blood by calculation

277

2163

1.26

3.43

4.6

3.6

mmol/l

2.2

0.11

173

1353

(44790049)

175

1286

1.34

3.42

1.6

1.7

—

(44790047)

175

1286

1.34

3.42

1.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1550

1.31

3.42

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

176

1295

1.34

3.42

1.3

1.5

—

(3021901) Oxygen saturation in Capillary blood

204

1533

1.31

3.42

2.8

3.1

—

(44806118)

175

1287

1.34

3.41

1.6

1.7

—

(44790048)

175

1287

1.34

3.41

1.6

1.7

—

(3027944) Amphetamines [Presence] in Urine

1230

10874

1.12

3.40

2.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

262

2035

1.27

3.40

2.4

3.2

umol/l

32.7

34.6

0.88

226

1779

(3015235) Bicarbonate [Moles/volume] in Capillary blood

284

2228

1.25

3.38

3.3

3.9

mmol/l

24.3

24.1

0.19

258

1963

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

175

1289

1.33

3.38

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

140

996

1.38

3.37

2.8

3.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

136

963

1.39

3.37

3.1

2.9

—

24.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

175

1291

1.33

3.35

1.4

—

(1616796) Gas panel - Central venous blood

271

2118

1.26

3.34

4.5

3.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

176

1300

1.33

3.34

1.3

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

190

1419

1.32

3.34

3.0

3.1

1.3

0.09

147

1113

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

617

1.48

3.29

1.1

—

(3024928) Oxygen saturation in Venous blood

255

1985

1.26

3.26

3.3

5.5

—

(3002619) Bacteria identified in Specimen by Culture

236

1.79

3.24

1.1

1.2

—

(3010421) pH of Blood

313

2496

1.23

3.24

4.5

3.6

7.4

0.50

273

2127

(3037121) Protein [Mass/volume] in Urine

440

3630

1.19

3.22

3.7

g/l

0.3

0.4

0.98

236

1740

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

137

980

1.37

3.21

2.4

2.8

nmol/l

5.4

9.4

0.30

131

945

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

1097

1.35

3.21

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

226

1739

1.28

3.19

1.8

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

159

1166

1.34

3.18

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

335

2696

1.22

3.18

2.0

ug/l

1.4

2.1

1.01

298

2409

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.86

3.17

1.1

1.0

—

(3022621) pH of Urine by Test strip

827

7173

1.14

3.16

2.8

2.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

142

1026

1.36

3.14

3.2

3.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

981

8605

1.13

3.13

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

143

1035

1.36

3.13

1.7

1.8

—

(40761536) Microorganisms panel - Urine sediment

1229

10919

1.11

3.13

3.9

3.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

232

1.78

3.12

1.3

1.2

pmol/l

585.0

380.9

0.54

176

(3036489) Thrombin time

585

4957

1.16

3.11

2.2

2.7

21.1

21.2

0.22

491

4228

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

363

2952

1.21

3.11

1.3

1.5

mmol/l

3.6

0.17

341

2777

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

142

1028

1.36

3.10

1.2

u/l

75.3

73.3

0.07

713

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.10

1.1

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

3850

35910

1.07

3.07

2.3

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1265

11269

1.11

3.06

3.7

3.5

31.3

32.0

1.50

955

8311

(3013512) EKG study

2693

24807

1.08

3.06

3.0

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

177

1327

1.31

3.06

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

341

2763

1.21

3.04

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

652

1.45

3.04

2.7

umol/l

163.3

171.6

0.09

333

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

472

3940

1.18

3.04

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

492

4129

1.17

2.98

2.6

3.5

g/l

3.4

3.5

0.54

462

3921

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

688

5921

1.15

2.97

2.0

2.1

ug/l

7.1

7.4

0.12

607

5210

(3002621) Streptococcal DNAse B [Units/volume] in Serum

172

1.88

2.95

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2928

27099

1.07

2.92

2.3

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

144

1059

1.34

2.87

1.5

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

382

1.57

2.86

1.0

1.3

102.1

103.2

0.10

362

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

758

6590

1.13

2.83

1.8

2.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.08

2.82

1.5

1.3

—

(3051651) Icteric interference index of Serum or Plasma

679

1.42

2.82

3.1

3.9

—

(3016244) Insulin [Units/volume] in Serum or Plasma

185

1413

1.29

2.81

3.2

3.3

mu/l

31.5

26.8

0.41

175

1335

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

244

1927

1.24

2.81

4.5

3.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

226

1772

1.25

2.78

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

362

1.57

2.77

1.1

80.9

85.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

609

1.43

2.75

23.0

28.2

ug/l

105.0

127.6

2.43

517

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

142

1050

1.33

2.75

1.0

1.1

mg/l

295.8

290.0

0.38

134

958

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

634

1.42

2.74

1.5

1.7

nmol/l

4.0

11.5

0.42

521

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

170

1.85

2.73

1.5

1.7

nmol/l

5.8

390517.2

1.50

137

(4035726)

911

8031

1.12

2.71

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

175

1335

1.29

2.70

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

170

1292

1.29

2.70

1.1

—

(3020891) Body temperature

380

3150

1.19

2.70

5.3

4.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

669

1.41

2.69

1.1

nmol/l

4.0

4.3

0.03

130

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

524

4460

1.16

2.68

9.1

10.9

—

(3014271) Vancomycin [Susceptibility]

245

1.68

2.63

2.3

2.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2274

20937

1.08

2.62

2.2

2.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

217

1708

1.25

2.61

3.2

5.7

66.0

65.4

0.15

217

1702

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

569

1.43

2.56

1.8

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

602

1.42

2.55

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

362

1.55

2.55

1.1

81.8

73.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

198

1547

1.26

2.54

1.3

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.74

2.54

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

379

1.53

2.51

3.1

3.4

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.53

2.51

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

286

2330

1.21

2.49

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

295

2413

1.20

2.46

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

108

781

1.36

2.46

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

108

781

1.36

2.46

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

108

781

1.36

2.46

1.8

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

356

2962

1.18

2.46

1.4

1.7

e6/l

373.4

2473.0

0.99

295

2381

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

756

1.36

2.46

1.5

1.4

e6/l

18437.8

70280.1

2.01

539

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

2.44

1.3

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

478

1.46

2.43

1.2

1.1

u/l

15.6

17.1

0.16

375

(3000093) Morphology [Interpretation] in Blood Narrative

122

901

1.33

2.42

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

407

1.49

2.41

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

113

827

1.34

2.39

1.1

miu/ml

1442.5

1489.4

0.18

113

827

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

355

2961

1.18

2.39

1.4

1.6

e6/l

13.6

22.9

1.17

279

2263

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

603

1.40

2.37

2.0

1.8

130.4

144.2

1.10

568

(3020393) Adenovirus Ag [Presence] in Stool

268

1.61

2.37

1.9

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1048

9382

1.10

2.36

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

481

1.45

2.36

1.2

1.1

u/l

73.9

79.2

0.35

392

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

646

5636

1.13

2.34

2.7

2.8

ng/l

146.1

137.2

0.20

570

5008

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

155

1192

1.28

2.31

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

476

1.44

2.29

1.1

ng/l

53.6

435.4

1.13

104

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

382

3218

1.17

2.29

1.4

u/l

20.2

21.3

0.31

307

2697

(3024263) Appearance of Synovial fluid

460

1.45

2.29

1.6

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3709

34840

1.06

2.28

3.1

2.8

—

(3049717) Cytology report of Urine Cyto stain

263

2147

1.20

2.27

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

230

1859

1.22

2.21

4.8

5.4

umol/l

372.9

380.5

0.34

206

1638

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

281

1.57

2.21

5.8

3.8

—

(4015189)

161

1.77

2.20

1.5

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

135

1028

1.29

2.19

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

135

1028

1.29

2.19

2.0

1.9

mg/l

23.7

24.2

0.04

290

(3004119) Hemoglobin [Mass/volume] in Venous blood

577

5029

1.13

2.15

3.4

4.4

g/l

132.5

131.6

0.47

566

4909

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

245

1.60

2.14

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

315

1.53

2.13

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

293

2432

1.18

2.13

1.8

pmol/l

192.6

181.5

0.82

273

2328

(3007919) Fasciola sp Ab [Titer] in Serum

3.27

2.13

1.0

—

(3036603) Volume of Urine

616

1.37

2.13

1.6

2715.6

2037.4

1.17

106

(3006653) Thiamine [Moles/volume] in Blood

583

1.38

2.12

1.3

1.4

nmol/l

135.7

134.6

0.09

583

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

114

854

1.31

2.10

1.1

—

(3042631) Mycobacterium sp identified in Specimen

117

881

1.30

2.08

3.5

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

362

3067

1.16

2.06

1.3

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

518

4500

1.13

2.05

2.4

3.4

95.8

94.0

1.11

475

4196

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

415

1.44

2.03

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

281

2338

1.18

2.01

1.3

u/ml

4.4

4.1

0.16

126

1060

(21494890) Protein electrophoresis panel - 24 hour Urine

606

1.36

2.01

2.2

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

490

1.40

2.00

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

281

1.54

1.99

6.3

7.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

107

802

1.31

1.98

1.5

1.6

34.2

36.7

0.27

507

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

186

1491

1.23

1.98

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

337

1.48

1.97

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

220

1.61

1.96

1.1

u/ml

—

30.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

338

1.48

1.95

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.76

1.95

1.0

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

448

3871

1.14

1.95

1.7

nmol/l

39.4

41.2

0.78

438

3801

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

712

1.32

1.93

1.7

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

229

1.58

1.92

1.1

1.0

ug/l

71.4

73.6

0.13

202

(3002256) Pathology report gross observation

1518

13943

1.07

1.91

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

372

1.45

1.91

1.5

1.4

umol/l

17.9

17.1

0.48

333

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

831

7446

1.10

1.90

4.2

3.5

mmol/l

1.2

0.01

744

6516

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1006

10676

0.92

1.89

1.4

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

162

1.70

1.88

6.1

5.3

ug/min

32.1

39.9

0.36

108

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

132

1025

1.26

1.88

1.6

52.2

51.8

0.03

662

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

164

1306

1.23

1.88

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

430

3716

1.14

1.88

1.6

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

116

888

1.28

1.86

2.6

2.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

141

1106

1.25

1.85

4.3

3.9

mmol/l

6.7

7.1

0.74

117

892

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

457

1.40

1.84

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

351

1.45

1.83

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

343

1.46

1.83

3.2

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

225

1.57

1.81

3.1

2.7

mg/l

23.6

36.5

—

(3019060) Gas panel - Arterial blood

551

4847

1.12

1.81

4.3

4.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

401

1.42

1.81

1.2

1.3

22.6

14.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

115

884

1.28

1.80

1.4

nmol/l

1.5

1.4

0.18

107

799

(40759632) Porphyrins [Mass/mass] in Stool

4.08

1.79

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

329

1.46

1.78

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

121

1.78

1.77

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

316

2687

1.16

1.76

4.4

3.8

mmol/l

1.4

0.07

308

2649

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

170

1370

1.22

1.76

1.2

mg/l

32.3

38.3

2.06

139

1147

(3030981) Hyaline casts [#/volume] in Urine by Automated count

562

4959

1.11

1.76

2.9

2.5

e6/l

0.2

0.3

1.07

543

4769

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.16

1.75

1.0

1.1

u/ml

0.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

470

1.38

1.75

2.8

2.0

—

(3045424) Erythrocytes [Presence] in Urine

230

1909

1.18

1.74

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

458

3997

1.13

1.74

2.1

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

1.77

1.73

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

278

2346

1.16

1.72

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

244

1.53

1.72

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

244

1.53

1.72

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

244

1.53

1.72

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

244

1.53

1.72

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

332

1.45

1.71

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

372

4131

0.88

1.69

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

269

1.50

1.68

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

641

5711

1.10

1.68

1.3

1.4

—

(40758358) Immune stain study

2.39

1.68

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

145

1156

1.23

1.68

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.61

1.68

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

268

2261

1.16

1.67

3.8

5.4

u/ml

0.3

0.06

130

1251

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

326

1.44

1.67

1.1

—

(3012565) Volume of 24 hour Urine

483

1.36

1.66

2.0

2.1

1988.1

2049.0

0.19

454

(3035933) Granulocytes/100 leukocytes in Blood

560

1.33

1.64

1.4

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

296

2523

1.15

1.62

2.2

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

545

1.33

1.61

1.9

2.0

nmol/l

1.2

1.3

0.45

436

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

164

1332

1.21

1.60

1.1

mg/l

210.7

225.3

0.58

145

1176

(4306422)

275

2336

1.16

1.59

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

284

2423

1.15

1.55

1.3

u/ml

4.1

3.6

0.15

850

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.45

1.55

11.9

5.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

617

1.30

1.55

1.5

1.6

u/l

6.4

4.9

0.29

316

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

146

1177

1.22

1.55

1.4

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

833

7547

1.09

1.54

1.3

miu/ml

213.1

232.5

0.89

418

3724

(3013336) Amino acids [Identifier] in Serum or Plasma

127

1.70

1.53

2.3

2.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

129

1028

1.23

1.53

1.2

1.3

mmol/l

1.8

1.9

0.05

124

963

(3042111) Morphology [Interpretation] in Bone marrow Narrative

141

1135

1.22

1.52

1.5

1.8

—

(3017509) Phencyclidine [Presence] in Urine

268

1.46

1.51

1.8

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

543

1.32

1.50

1.8

1.6

u/field

4.1

2.5

0.27

406

(40763791) Oxygen content in Venous blood by calculation

2.45

1.48

3.0

9.1

ml/dl

11.0

13.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3167

29948

1.05

1.48

1.6

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.06

1.47

2.0

2.1

umol/l

42.3

43.9

0.07

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

144

1.63

1.46

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

840

1.25

1.46

2.8

3.1

57.6

56.3

0.21

533

(3030313) Adrenal Ab [Titer] in Serum

215

1.51

1.44

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

236

0.54

1.44

5.8

7.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

162

1332

1.19

1.42

1.3

nmol/l

29.0

33.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

540

4819

1.10

1.42

6.7

6.8

mmol/l

24.5

24.3

0.59

510

4487

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

200

1.52

1.41

1.4

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

138

1.63

1.41

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

127

1021

1.22

1.41

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

118

942

1.23

1.40

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

412

3628

1.12

1.40

2.0

1.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

266

2280

1.15

1.39

4.8

4.0

mmol/l

3.8

0.61

251

2145

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

290

1.42

1.38

1.2

1.3

nmol/l

200.0

111.2

1.22

222

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

936

1.23

1.37

1.1

—

(3000012) Reticulocyte production index

424

1.34

1.37

1.3

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

647

1.27

1.37

1.9

mg/l

3.4

3.5

0.10

615

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

742

0.75

1.36

1.5

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

727

1.26

1.34

1.1

—

(3016038) Potassium [Moles/volume] in Urine

571

1.29

1.34

1.6

2.0

mmol/l

35.2

0.00

515

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.13

1.33

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.88

1.33

1.2

1.1

mg/l

1.4

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

117

940

1.22

1.32

2.0

2.2

32.0

32.5

0.58

117

933

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

765

1.24

1.31

2.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

394

3480

1.11

1.29

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

252

0.58

1.29

5.7

7.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

173

1.53

1.29

2.8

2.5

—

(3045142) Bone marrow Pathology biopsy report

108

864

1.23

1.28

1.3

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.83

1.26

1.0

1.3

umol/24h

0.4

0.8

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

2.72

1.25

1.2

nmol/l

273.2

229.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

682

1.25

2.5

2.7

44.3

42.1

0.49

227

(37021550) Renin [Units/volume] in Plasma --upright

223

1.45

1.24

1.4

mu/l

89.7

115.6

0.20

181

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

183

1.50

1.23

1.9

1.6

ug/l

0.4

0.24

133

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.77

1.23

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

284

2475

1.13

1.20

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.58

1.19

1.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1606

16473

0.95

1.18

1.5

—

(21494434) Karyotype in Bone marrow

636

1.25

1.16

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

181

1534

1.16

2.4

3.3

u/ml

5644.1

295.7

0.50

168

1390

(3027874) Urate [Moles/volume] in Urine

0.00

1.16

0.0

1.1

—

1.9

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

186

1.48

1.16

1.3

1.2

mg/l

0.4

111.6

1.90

135

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

335

1.35

1.15

2.7

2.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.59

1.15

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

252

1.40

1.14

1.4

51.6

49.2

0.14

222

(3013727) Leukocytes other/100 leukocytes in Blood

302

1.36

1.14

4.4

3.6

48.2

50.7

0.33

293

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

682

1.24

1.14

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

604

1.25

1.13

1.2

u/l

82.5

81.7

0.02

536

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.01

1.12

2.1

2.4

umol/l

0.5

0.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

282

2469

1.12

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

588

1.25

1.11

1.2

u/l

24.9

17.7

0.31

514

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

109

1.62

1.10

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

117

1.59

1.09

1.3

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

382

1.31

1.08

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

382

1.31

1.08

1.3

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

238

2070

1.13

1.07

1.8

1.7

titre

2186.7

1926.9

0.08

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

256

2237

1.12

1.07

1.1

115.8

116.5

0.15

225

2061

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

435

1.29

1.05

2.7

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

435

1.29

1.05

2.7

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

286

2518

1.12

1.05

2.1

1.9

titre

2.5

6.9

1.02

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

717

1.22

1.04

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.75

1.04

1.2

1.4

pmol/l

14.7

19.7

0.53

(4268621)

192

1651

1.14

1.04

2.4

2.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.08

1.03

1.6

1.1

nmol/l

400.3

233.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

249

1.38

1.03

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1066

11009

0.95

1.03

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

1606

1.14

1.03

1.2

1.1

97.2

94.3

0.69

169

1526

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

1.02

1.1

—

(3003694) ABO and Rh group [Type] in Blood

4248

42594

0.97

1.02

1.7

—

(4027681)

132

1106

1.17

1.01

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

587

1.24

1.01

1.2

1.3

u/l

181.1

287.7

2.37

542

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

395

1.29

1.01

2.8

2.7

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.23

1.01

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

318

1.33

1.00

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

482

1.26

1.00

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

659

1.22

0.99

2.0

1.9

g/24h

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2981

28394

1.04

0.99

1.8

1.7

—

(3019174) dRVVT (LA screen)

145

1.49

0.97

1.3

1.2

—

(4024509)

106

876

1.19

0.97

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.80

0.97

6.7

4.8

—

(3001729) Color of Synovial fluid

1.80

0.97

1.4

1.8

—

(44806071)

203

1.40

0.95

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

287

1.33

0.95

3.2

2.5

mmol/l

1.7

1.6

0.13

212

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

451

1.26

0.95

2.3

ng/l

111.7

117.7

0.13

323

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

170

1462

1.14

0.94

1.6

1.7

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.26

0.94

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

523

1.24

0.93

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

142

0.55

0.92

1.1

1.5

38.6

27.3

—

130

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

188

1.41

0.92

4.3

6.3

mg/l

2.1

2.5

0.59

163

(3037692) Legionella sp identified in Specimen by Organism specific culture

289

1.32

0.92

1.7

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

471

1.25

0.92

1.6

mmol/24h

6.4

5.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

205

1.39

0.91

1.9

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.70

0.90

1.2

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.10

0.90

7.3

3.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

740

1.19

0.89

1.5

1.7

iu/ml

1112363.8

1636523.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.87

0.87

1.1

1.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

182

1.40

0.87

1.3

—

89.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

292

1.31

0.87

1.3

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.78

0.87

1.0

iu/ml

5.6

16.0

—

(3023410) Appearance of Cerebral spinal fluid

169

1464

1.13

0.86

1.6

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

493

1.23

0.86

1.5

1.4

pmol/l

13.5

14.0

0.51

420

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

765

0.82

0.85

6.6

6.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

380

1.26

0.84

2.7

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5866

56581

1.03

0.84

4.0

3.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

105

881

1.17

0.84

1.1

u/l

1.0

1.94

368

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

805

7481

1.06

0.83

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

136

0.58

0.83

8.9

8.0

—

(3015183) Erythrocyte sedimentation rate

102

855

1.17

0.83

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

434

1.24

0.83

1.3

1.2

—

(4211845)

585

1.21

0.82

3.3

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

772

0.82

2.4

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

114

965

1.16

0.82

1.4

1.5

—

(4281824)

1111

0.85

0.82

1.2

1.1

—

(4198724)

137

1176

1.14

0.81

2.6

2.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

396

3598

1.08

0.81

1.6

1.5

nmol/l

0.4

1.22

310

2935

(3040893) Potassium [Moles/volume] in Capillary blood

1.70

0.80

2.6

3.3

mmol/l

4.2

4.5

—

(3033799) Differential panel - Peritoneal fluid

219

1.34

0.80

1.8

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

498

1.22

0.80

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

445

1.23

0.80

1.2

1.1

u/ml

65.7

56.7

0.39

435

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.84

0.80

1.0

1.6

mu/l

1.2

2.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

409

3724

1.08

0.79

3.6

3.7

mmol/l

25.0

25.1

0.38

396

3587

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

136

1.44

0.79

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

863

8054

1.05

0.78

1.5

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.78

0.0

1.6

—

2.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

491

1.22

0.78

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

212

1.34

0.77

1.4

1.3

50.9

39.5

0.84

150

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.78

0.77

6.0

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

395

4162

0.93

0.77

1.4

1.3

ug/l

5.1

3.7

1.28

358

3881

(3035880) pH of Pleural fluid

275

0.71

0.77

1.7

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

245

2186

1.10

0.77

3.5

2.6

nmol/l

0.8

0.13

201

1856

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.77

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

221

1.33

0.76

1.3

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.76

1.0

1.1

u/l

5.6

13.0

1.17

(43055514) Macroprolactin [Presence] in Serum or Plasma

654

1.18

0.76

1.4

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.13

0.75

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.54

0.75

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

387

1.24

0.75

1.0

ng/l

261.2

315.0

1.33

277

(3051387) C reactive protein [Mass/volume] in Capillary blood

257

2304

1.09

0.74

3.2

3.1

mg/l

21.8

24.3

0.71

152

1398

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.63

0.73

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

371

1.24

0.73

2.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

371

1.24

0.73

2.0

2.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

106

1.48

0.72

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

137

1514

0.89

0.72

2.8

mmol/l

1.4

1.5

0.10

132

1477

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

694

1.17

0.72

1.9

u/field

2.0

0.04

353

(3003577) Lead [Moles/volume] in Blood

107

0.55

0.72

1.0

1.4

—

0.2

—

(3024869) Neuronal Ab [Presence] in Serum

131

1.42

0.71

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

390

1.23

0.71

1.0

ng/l

33.1

43.2

1.81

270

(3034891) Synovial lining cells/100 cells in Synovial fluid

417

1.22

0.70

1.4

1.5

2.2

4.2

1.09

105

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

217

1.31

0.68

2.3

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

116

1.44

0.68

1.1

1.2

ug/l

8.5

339.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

446

1.21

0.68

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

482

1.20

0.67

1.8

1.9

—

(40765096) Chromosome analysis panel by Banding

235

1.29

0.67

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

528

1.19

0.66

3.3

2.4

—

(3049233) Organic acids panel - Urine

1.55

0.66

1.5

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

150

1.37

0.66

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

502

1.19

0.65

4.5

5.2

mg/l

81.1

2622.7

2.06

383

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

738

1.16

0.65

1.6

2.3

ug/l

38.0

22.8

0.60

725

(3032057) Clostridioides difficile [Presence] in Stool

159

1.36

0.65

1.6

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

1106

1.13

0.65

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.75

0.65

1.2

1.1

g/l

0.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

684

1.16

0.64

1.1

1.3

66.0

73.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

254

0.73

0.64

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

263

1.27

0.64

2.2

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

865

0.86

0.64

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.61

0.64

2.1

1.8

—

(3045462) Protein/Creatinine [Ratio] in Urine

316

1.24

0.64

7.3

6.1

g/mol

45.7

242.6

0.69

288

(3001019) Free T4 and TSH panel - Serum or Plasma

1034

9753

1.04

0.63

1.7

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

160

1416

1.11

0.63

1.3

umol/l

5.0

5.9

2.59

151

1311

(3028308) Erythrocytes [#/volume] in Pleural fluid

559

1.18

0.62

1.6

1.4

e6/l

50164.6

56580.5

0.10

333

(3020491) Glucose [Moles/volume] in Blood

109

944

1.13

0.62

1.9

1.6

mmol/l

6.2

6.0

0.26

741

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

596

1.17

0.62

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

141

1241

1.11

0.62

2.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

380

1.21

0.61

2.0

2.1

—

(3012441) Differential panel - Pleural fluid

542

1.18

0.61

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

144

1.36

0.61

1.1

1.0

—

(4094501)

267

2424

1.08

0.61

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

386

3553

1.07

0.61

2.0

iu/l

5.2

6.4

0.24

168

1469

(3014891) Appearance of Pleural fluid

1.58

0.60

2.7

1.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.60

0.0

1.5

—

2831.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

288

2625

1.08

0.60

3.4

3.6

u/ml

459.0

2090.4

0.86

259

2256

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

390

1.21

0.60

1.0

ng/l

883.3

767.0

1.01

271

(3005082) Progesterone [Moles/volume] in Serum or Plasma

151

1636

0.90

0.60

1.5

1.4

nmol/l

31.1

32.0

0.14

137

1519

(40761995) Spermatozoa Progressive [#/volume] in Semen

446

0.81

0.59

3.2

3.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

481

1.18

0.59

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

481

1.18

0.59

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

481

1.18

0.59

1.8

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

169

1507

1.10

0.59

1.4

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

445

0.81

0.58

6.3

6.0

—

(3045716) Anion gap in Serum or Plasma

365

1.21

0.58

2.1

2.6

mmol/l

9.8

9.5

0.15

277

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

898

8467

1.04

0.58

1.9

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

134

1183

1.11

0.57

1.5

promille

1.5

1.3

0.64

903

(3034614) HLA Ag [Interpretation]

1.68

0.57

1.2

—

(3044927) Protein electrophoresis panel - Urine

574

1.16

0.57

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

456

1.18

0.57

5.0

4.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

375

1.20

0.56

3.1

2.8

umol/l

28.2

0.01

266

(3001556) Androgen free Index in Serum or Plasma

286

1.23

0.56

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

121

1.38

0.56

1.1

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

216

1.27

0.56

1.8

3.6

9.7

5.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.45

0.55

6.5

6.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

787

1.13

0.55

2.1

1.9

—

(40768793) Breast Pathology biopsy report

253

2664

0.93

0.55

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

156

1.32

0.54

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.54

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

359

1.20

0.54

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

359

1.20

0.54

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

359

1.20

0.54

1.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.55

0.53

1.0

—

(3019977) pH of Arterial blood

433

1.18

0.52

2.3

2.8

7.4

0.10

125

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

691

7054

0.96

0.52

2.7

u/ml

28.0

38.4

2.74

669

6807

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.62

0.52

1.5

7.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

257

2351

1.07

0.51

1.5

mmol/l

6.8

6.7

0.35

191

1676

(3041354) Potassium [Moles/volume] in Venous blood

795

0.87

0.51

2.3

2.1

mmol/l

4.0

0.08

786

(3044242) Glucose [Moles/volume] in Arterial blood

353

1.19

0.51

2.0

2.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.47

0.50

3.2

5.7

mmol/l

0.4

0.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

211

1.25

0.50

3.1

3.9

u/l

138.5

55.7

0.32

(3035285) Chloride [Moles/volume] in Venous blood

792

0.88

0.49

2.3

2.1

mmol/l

106.0

105.6

0.28

783

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

564

1.15

0.49

7.2

6.5

u/ml

85.4

5910.7

0.58

121

(3051101) Glucose [Moles/volume] in Cord blood

105

0.65

0.48

5.3

6.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

267

2458

1.07

0.46

1.7

1.6

mmol/l

7.4

7.5

0.41

164

1471

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

652

6147

1.04

0.46

1.6

mg/l

3.6

3.5

0.11

459

4129

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

313

1.19

0.45

1.9

2.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

188

1.25

0.45

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.42

0.44

4.7

2.4

umol/l

32.0

37.1

0.71

(40768806) Pleura Pathology biopsy report

544

1.14

0.42

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

1838

18386

0.98

0.42

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.58

0.42

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.43

0.42

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

699

6617

1.04

0.42

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

190

1.24

0.42

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

190

1.24

0.42

2.8

4.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

1030

1.09

0.41

1.2

ratio

1.1

0.05

372

(3050794) Legionella sp Ab [Presence] in Serum

1.36

0.41

1.0

1.1

—

(3011648) Oxygen content in Venous blood

871

1.10

0.41

3.9

6.8

11.8

11.3

0.72

871

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

28.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

179

1881

0.93

0.41

3.8

3.4

—

(3000330) Specific gravity of Urine by Test strip

482

4531

1.04

0.41

3.3

2.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

103

1.33

0.40

1.0

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

466

0.86

0.39

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.44

0.39

1.4

1.1

mmol/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.44

0.39

1.0

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.44

0.39

1.0

1.2

u/field

2.0

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.44

0.39

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

799

1.10

0.39

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

790

1.10

0.39

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

663

0.89

0.39

1.2

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

632

1.12

0.39

1.7

1.4

e6/l

2610.8

2969.9

0.20

458

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

671

6360

1.04

0.38

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

118

1256

0.92

0.38

1.5

1.2

u/l

54.5

33.5

0.34

104

1101

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

429

1.14

0.38

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.36

0.37

1.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.65

0.35

1.0

5.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.43

0.35

1.5

4.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

314

0.84

0.35

1.2

1.6

—

(3000285) Sodium [Moles/volume] in Blood

1.31

0.35

1.5

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.37

0.34

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

268

1.17

0.34

2.7

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

268

1.17

0.34

2.7

2.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

124

1.26

0.34

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

509

1.12

0.33

1.7

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

777

0.91

0.33

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

132

1387

0.93

0.33

3.9

4.4

u/ml

107.0

99.0

0.06

452

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

104

1103

0.92

0.33

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.69

0.33

1.5

1.7

—

(3017704) Immunofixation for Urine

332

0.86

0.32

1.7

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.33

0.32

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

143

1.23

0.32

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

152

1.23

0.32

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1745

16831

1.02

0.29

3.7

ug/l

2.2

2.1

0.22

1575

15337

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

190

1.19

0.29

1.4

1.7

mg/l

1.7

0.05

168

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

337

1.13

0.29

1.4

1.7

—

426.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

154

1.21

0.29

1.7

2.2

mmol/l

6.8

7.2

0.15

(4038314)

127

0.77

0.28

1.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

234

2192

1.05

0.27

1.1

iu/ml

154.0

4726.8

0.63

576

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

137

1.22

0.27

1.2

1.4

72.5

60.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

116

0.76

0.27

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.23

0.27

4.0

3.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

180

1677

1.05

0.27

1.5

mmol/l

12.7

11.5

0.58

257

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

346

0.88

0.26

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

763

7306

1.02

0.26

3.4

3.9

ug/l

53.7

21.4

0.60

591

5446

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

111

1.24

0.26

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

0.67

0.26

4.8

2.2

umol/l

289.2

252.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.67

0.26

2.8

1.4

u/l

45.4

519.6

—

(3042517) Benzodiazepines panel - Urine

304

1.13

0.25

4.6

2.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.19

0.24

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1012

9734

1.02

0.24

2.5

ug/l

0.6

0.7

0.95

576

5343

(3032868) Hemoglobin electrophoresis panel in Blood

177

0.83

0.24

1.4

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

417

1.10

0.24

2.0

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

700

1.08

0.24

2.8

3.0

nmol/l

0.9

0.8

0.53

515

(3036670) Protein [Mass/volume] in Synovial fluid

185

1.17

0.24

1.4

1.2

g/l

41.3

38.6

0.35

101

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1696

16849

0.98

0.24

1.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

333

3157

1.03

0.24

3.6

5.3

1.9

1.7

0.79

310

2942

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.71

0.24

1.5

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

196

1838

1.05

0.24

2.9

2.5

ug/min

89.9

113.6

0.34

128

1188

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

241

1.14

0.23

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

259

0.87

0.23

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

186

1.16

0.23

2.1

1.5

—

(3006270) Folate [Moles/volume] in Blood

788

1.07

0.23

1.2

1.1

nmol/l

398.9

406.0

0.12

732

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.29

0.23

1.8

1.3

nmol/l

163.6

116.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

123

1141

1.06

0.23

10.8

11.8

mmol/l

0.6

1.66

116

1047

(3007463) Buprenorphine [Presence] in Urine

104

1.23

0.23

3.7

5.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

940

0.94

0.22

1.4

1.3

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1335

13268

0.98

0.21

3.3

21.4

21.5

0.04

478

4998

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

197

1.14

0.21

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

105

973

1.06

0.21

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

225

1.13

0.21

1.5

1.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

7.0

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

0.00

0.20

0.0

1.4

—

0.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

225

0.87

0.20

2.5

4.4

mmol/l

1.2

0.23

207

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

183

0.86

0.20

9.1

7.5

—

(46236302) HLA-C [Type] by High resolution typing

1.20

0.19

1.0

—

(40763590) HLA-DQ beta [Type]

1.20

0.19

1.0

—

(3013862) HLA-DP [Type]

1.18

0.19

1.0

—

(3004451) EKG impression Narrative

311

1.10

0.19

1.6

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

738

1.06

0.19

1.1

94.9

92.6

0.25

602

(3032352) Blasts [#/volume] in Cerebral spinal fluid

153

1.15

0.18

1.7

4.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.20

0.18

1.1

—

(3047181) Lactate [Moles/volume] in Blood

298

2840

1.03

0.18

4.1

5.6

mmol/l

1.3

1.2

0.10

263

2499

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.18

0.18

1.1

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.18

0.18

1.0

1.2

mg/l

0.0

0.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

219

1.12

0.17

1.2

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

332

3338

0.97

0.17

1.4

1.5

pmol/l

69.0

99.5

1.97

323

3244

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

266

1.11

0.17

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

547

0.93

0.17

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.12

0.17

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

389

1.08

0.17

1.9

2.0

ug/min

71.4

95.2

0.19

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

154

1.15

0.17

2.2

1.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

117

1.17

0.17

4.8

4.9

—

(3000034) Microalbumin [Mass/volume] in Urine

818

0.95

0.17

3.1

2.8

mg/l

35.4

62.6

0.98

598

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.15

0.16

1.3

1.2

—

(4146454)

716

0.94

0.16

2.7

2.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

118

1.16

0.15

5.9

9.5

mmol/l

4.7

5.7

1.42

118

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

118

1.16

0.15

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.77

0.15

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

915

0.95

0.15

1.4

1.5

—

(3016750) Collection duration of Urine

458

1.07

0.15

2.9

2.3

min

501.1

504.2

0.09

370

(4034850)

354

3393

1.02

0.15

8.8

7.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

203

1.11

0.14

1.6

1.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.79

0.14

1.3

1.4

umol/24h

303.7

305.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.78

0.14

2.6

3.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

195

1965

0.97

0.13

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

248

0.91

0.13

2.2

4.8

mmol/l

1.2

0.25

232

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

120

1.14

0.13

5.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

120

1.14

0.13

1.1

1.6

—

9.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

0.82

0.13

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

196

0.90

0.12

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

301

1.07

0.12

2.9

2.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

837

0.96

0.11

1.2

1.3

g/l

1.6

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

230

2303

0.98

0.11

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

284

2731

1.02

0.11

1.7

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

188

1.09

0.11

1.1

umol/24h

1.5

1.0

—

102

(3039000) Anion gap in Blood

192

1839

1.02

0.10

4.6

7.1

mmol/l

11.4

11.3

0.08

176

1648

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

943

0.97

0.10

1.3

pmol/l

147.7

92.1

0.31

289

(40758292) HTLV I+II Ab panel - Serum

234

0.92

0.10

1.3

—

(3018572) Chloride [Moles/volume] in Blood

192

1840

1.02

0.10

4.6

7.1

mmol/l

104.9

105.5

1.16

176

1649

(3041806) Other cells [#/volume] in Blood by Manual count

139

1399

0.97

0.10

1.9

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.14

0.10

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

237

1.08

0.09

4.0

8.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

323

3117

1.02

0.09

3.7

5.3

0.9

0.46

300

2912

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

680

1.04

0.09

1.3

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

692

0.96

0.09

1.2

—

(4212803)

1.09

0.08

1.0

1.1

—

(3032641) Amino acids panel - Urine

1.05

0.08

2.2

1.1

—

(4133840)

372

0.95

0.08

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

799

0.97

0.08

1.8

1.4

umol/l

69.8

69.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

258

1.06

0.08

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.09

0.08

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

105

1056

0.97

0.08

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

231

0.93

0.08

1.7

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.07

0.07

1.1

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.06

0.07

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

192

1.07

0.07

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

346

1.05

0.07

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.05

0.07

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

148

1478

0.98

0.07

1.5

—

(3024932) HLA-DR beta [Type]

458

0.96

0.06

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

0.87

0.06

1.0

1.1

umol/24h

1.8

—

101

(44806420)

129

0.91

0.06

2.6

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

121

1163

1.02

0.06

18.9

19.2

nmol/l

1448.1

2223.1

0.46

116

1119

(3029396) Erythrocyte agglutination [Presence] in Blood

862

0.98

0.05

3.4

3.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

708

1.02

0.05

1.2

—

(3004775) Volume in Urine collected for unspecified duration

574

0.97

0.05

2.9

2.3

694.2

628.6

0.55

430

(3024471) HLA-A [Type]

465

0.97

0.05

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

216

2141

0.99

0.05

2.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

108

1.09

0.04

1.6

2.2

u/field

0.7

0.06

108

(3048879) Bone marrow aspiration report

166

1.06

0.04

1.3

2.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

195

1.06

0.04

2.3

6.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

345

0.97

0.04

3.0

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

679

0.98

0.03

1.6

1.7

—

(3034426) Prothrombin time (PT)

537

1.02

0.03

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

645

1.02

0.03

2.6

2.7

umol/l

53.1

0.00

571

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

175

0.95

0.02

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

603

5887

1.00

0.02

1.6

1.5

—

(40768441) Liver Pathology biopsy report

880

1.01

0.02

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

237

1.03

0.02

1.8

2.1

e6/l

6897.2

16073.0

—

125

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.08

0.02

2.5

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

142

1400

0.99

0.01

3.4

3.5

u/ml

262.7

423.0

0.25

132

1282

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

170

1.04

0.01

2.0

3.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

180

1.03

0.01

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

200

1.03

0.00

1.2

1.5

ng/l

30.3

62.0

1.17

115

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

249

1.02

0.00

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

133

0.96

0.00

1.5

2.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

111

0.97

0.00

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

183

1.02

0.00

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

218

0.99

0.00

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

376

0.99

0.00

1.2

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

558

1.00

0.00

1.1

—

(3022689) Creatine [Moles/volume] in Urine

280

1.02

0.00

1.8

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

265

1.00

0.00

1.8

2.3

e6/l

651.1

819.6

0.25

183

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

486

1.01

0.00

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

144

1.02

0.00

2.0

1.7

—

(3022670) pH of Venous cord blood

115

1.02

0.00

1.1

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

157

1.00

0.00

1.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

215

1.00

0.00

2.0

2.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

260

1.02

0.00

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

803

1.00

0.00

1.2

u/ml

7.4

16.0

0.55

(3020356) Listeria sp identified in Specimen by Organism specific culture

171

0.97

0.00

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

222

1.02

0.00

2.1

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

230

0.98

0.00

1.5

1.9

ug/l

2.8

3.5

0.17

136

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

15.2

—

6.1

—

(40760409) HLA-A [Type] by High resolution

1.00

0.00

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

1.00

0.00

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3025315) Body weight

0.96

0.00

3.3

3.4

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

101.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

32.1

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.97

0.00

1.0

1.1

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

11.4

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.92

0.00

7.3

6.7

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ATOPIC_STRICT – Atopic dermatitis, strict definition

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Atopic dermatitis, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Atopic dermatitis, strict definition (ATOPIC_STRICT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints